MRF-Annual Report-2019-2020-28 Dec 2020-10-2-2021.cdr

OLD NO.18, NEW NO.41, COLLEGE ROAD, CHENNAI 600 006

MEDICAL RESEARCH FOUNDATION

ANNUAL REPORT & ACCOUNTS2019 - 2020

To

The Members of the Medical Research FoundationNovember 27, 2020

Contd…2

NOTICE

AGENDA

1

NOTICE IS HEREBY GIVEN TO THE MEMBERS OF THE MEDICAL RESEARCH FOUNDATION ndTHAT THE 42 ANNUAL GENERAL MEETING OF THE FOUNDATION WILL BE HELD ON

SATURDAY, THE 19th DECEMBER 2020 AT 6.00 P.M. THE MEETING WILL BE HELD ONLINE

DUE TO THE PREVAILING COVID PANDEMIC.

1. To consider and adopt the Audited Income and Expenditure Account for the year

ended March 31, 2020 and the Balance Sheet as at that date together with the

Report of the Auditors thereon.

2. To consider and adopt the Annual report of the Foundation for the year 2019-20

3. To appoint Auditors and to fix their remuneration for the year ending 31st March

2021.

4. To elect Members to the Board of Management in the vacancies caused by the

retirement of the following Members, who being eligible offer themselves for re-

appointment


Sl. No Name Category Of Membership

1 Mr. Ashok Kumar Mehta Donor member

2 Mr. Mani S Subramonian Patron member

3 Mr. B S Taraporevala Patron member

4 Dr. Girish Shiva Rao Honorary member

Kindly make it convenient to attend the meeting.

Encl: 1. Explanatory statement for Item 4 of the Agenda 2. Audited Accounts for the year ended March 31, 2019

G. RAMACHANDRAN

Honorary Secretary & Treasurer

2


5. To elect Members to the Board of Management in the existing vacancy.

6. To amend clauses of MoA and Bye-laws of Medical Research Foundation as per

current laws and financial position

Their term of appointment expires on 29th September 2020. As per 11(v) of the Bye-laws of

the Foundation read with Section 15(5) of the Tamil Nadu Societies Registration Act 1975,

they are eligible for reappointment to the Board of Management. They have offered

themselves for reappointment.

As per rule no 10(c) of the Memorandum of Association and Bye laws of the Foundation, the 2

directors Mr. B S Taraporevala and Mr. Mani S Subramonian who represent Sir Ratan Tata Trust

and M/s Jaslok Hospital and Research Centre respectively are eligible for automatic re-

election. In the absence of any specific notice to the Foundation from these two

organizations notifying change of their nominees, these 2 members will get elected

automatically.

3

Explanatory statement for Item 4 of the Agenda


To amend clauses of MoA and Bye-laws of Medical Research Foundation stated as below:

4

Explanatory statement for Item 6 of the Agenda


10 (I) MEMBERSHIP:

10 (c ) Patron Members:

Persons or Firms or Institutions or Corporate Bodies making a lump sum donation of Rs. 50 Lakhs or more may be invited to become Patron Members. Firms/Institutions/Corporate Bodies, who have become Patron Members, are entitled to nominate one representative to exercise their rights and privileges of membership by a resolution passed by their respective Board. In case the nominated person is to be elected to the Board of Management, the Firms/Institutions/Corporate Bodies shall duly authorize the same person to function as a member of the Management in any capacity. As far as the Patron Member, M/s Jaslok Hospital and Research Centre, 15 Dr. G. Deshmukh Marg, Mumbai 400 026, is concerned, they are entitled to nominate 2 representatives as their nominees to the Board of Management. The Patron Members, M/s Keligavan Investment and Trading Private Limited, M/s Jamwadi Investment Trading Private Limited, Sir Ratan Tata Trust and Essel Mining and Industries Limited, Kolkata are entitled to nominate as any other Patron Member [with the exception of M/s Jaslok Hospital and Research Centre] one representative each as their nominee to the Board of Management. The nominees of the above Patron Members, namely, M/s. Jaslok Hospital and Research Center, M/s Keligavan Investment and Trading Private Limited, M/s Jamwadi Investment Trading Private Limited, Sir Ratan Tata Trust and Essel Mining and Industries Limited, Kolkata shall be entitled to be elected as the Members of the Board of Management and shall be automatically entitled to be re-elected upon completion of the term unless the said Patron Members desire to appoint other nominees in place of the retiring nominees.

EXISTING CLAUSE

10 (I) MEMBERSHIP:

10 (c )Patron Members:

Henceforth, Persons or Firms or Institutions or Corporate Bodies making a lump sum donation of Rs. 500 Lakhs or more may be invited to become Patron Members. This increase will not disqualify any of the current patron members Firms/Institutions/Corporate Bodies, who have become Patron Members, are entitled to nominate one representative to exercise their rights and privileges of membership by a resolution passed by their respective Board. In case the nominated person is to be elected to t h e B o a r d o f M a n a g e m e n t , t h e Firms/Institutions/Corporate Bodies shall duly authorize the same person to function as a member of the Management in any capacity. As far as the Patron Member, M/s Jaslok Hospital and Research Centre, 15 Dr. G. Deshmukh Marg, Mumbai 400 026, is concerned, they are entitled to nominate 2 representatives as their nominees to the Board of Management. The Patron Members, M/s John Fowler Ocular Lenses Private Limited, M/s Jamwadi Investment Trading Private Limited, Sir Ratan Tata Trust and Essel Mining and Industries Limited, Kolkata are entitled to nominate as any other Patron Member [with the exception of M/s Jaslok Hospital and Research Centre] one representative each as their nominee to the Board of Management. The nominees of the above Patron Members, namely, M/s. Jaslok Hospital and Research Center, M/s John Fowler Ocular Lenses Private Limited , M/s Jamwadi Investment Trading Private Limited, Sir Ratan Tata Trust and Essel Mining and Industries Limited, Kolkata shall be entitled to be elected as the Members of the Board of Management and shall be automatically entitled to be re-elected upon completion of the term unless the said Patron Members desire to appoint other nominees in place of the retiring nominees.

PROPOSED CLAUSE

5


10 (d) Donor Members :

Persons or Firms or Institutions or Corporate Bodies making a lump-sum donation of Rs.25 Lakhs or more but less than Rs.50 Lakhs may be invited to become DONOR MEMBERS. Firms / Institutions / Corporate Bodies who have become DONOR MEMBERS are entitled to nominate one representative to exercise their rights and privileges of membership, by a resolution duly passed by the Board. In case the nominated person is to be elected to the Board of Management, the Firms / Institutions /Corporate Bodies shall duly authorize the same person to function as a member of the Board of Management in any capacity.

10 (e) Associate Members:

Persons / Firms/ Institutions / Corporate Bodies contributing a lump sum donation of Rs.1,00,000/-or more but less than Rs 5,00,000/- shall be eligible to become ASSOCIATE MEMBERS.

(ii) REMOVAL OF MEMBERS:

Any member of the Foundation who is of unsound mind or who is an undischarged insolvent or has at any time been adjudged as insolvent or has at any time been convicted by a Court of an offence involving moral turpitude, shall be removed from the membership of the Foundation by the Board of Management and an appeal shall lie against such removal to the General Body of the Foundation and the decision of the General Body shall be final.

EXISTING CLAUSE

10 (d) Donor Members :

Henceforth Persons or Firms or Institutions or Corporate Bodies making a lump-sum donation of Rs.100 Lakhs or more but less than Rs. 500 Lakhs may be invited to become DONOR MEMBERS. This increase will not disqualify any of the current Donor members. Firms / Institutions / Corporate Bodies who have become DONOR MEMBERS are entitled to nominate one representative to exercise their rights and privileges of membership, by a resolution duly passed by the Board. In case the nominated person is to be elected to the Board of Management, the Firms /Institutions /Corporate Bodies shall duly authorize the same person to function as a member of the Board of Management in any capacity.

10 (e) Associate Members:

To remove Associate member category since it has lost its relevance

(ii) REMOVAL OF MEMBERS:

Any member of the Foundation who is of unsound mind or who is an undischarged insolvent or has at any time been adjudged as insolvent or has at any time been convicted by a Court of an offence involving moral turpitude, shall be removed from the membership of the Foundation by the Board of Management and an appeal shall lie against such removal to the General Body of the Foundation and the decision of the General Body shall be final. Members who have not attended any two consecutive General Body Meetings (AGM/EGM) shall be removed from the membership of the Foundation by the Board of Management and an appeal shall lie against such removal to the General Body of the Foundation and the decision of the General Body shall be final

PROPOSED CLAUSE

6


13. THE BOARD OF MANAGEMENT: (hereinafter called the 'Board')

ii. “The members constituting the Board shall not be more than Thirty Three out of which One member shall be from Founder member, eight members shall be from Patron members including patron members described under 10 (c) above, thirteen members shall be Donor members, and eleven members shall be Honorary members. Of these eleven Honorary members, Six members can be elected from amongst the Ophthalmic consultants and Senior Executives permanently employed by MRF and scientists permanently employed by Vision Research Foundation, and the balance five Honorary Members not employed by MRF. As far as M/s Jaslok Hospital and Research Center is concerned they are entitled to nominate two persons to the Board of Management. The persons nominated by M/s Jaslok Hospital and Research Center, M/s Keligavan Investment and Trading (P) Ltd., M/s Jamwadi Investment Trading (P) Ltd, Sir Ratan Tata Trust, Essel Mining and Industries Limited, Kolkata are entitled to be elected as members of the Board of Management as stipulated under clause 10(c) of the bye laws”

16. MEETINGS & RESOLUTIONS:

I. The President shall preside at the Board Meetings and in his absence the Vice President. In the absence of both, a Chairman shall be elected from among the members present to conduct the proceeding of the meetings.

EXISTING CLAUSE

13. THE BOARD OF MANAGEMENT: (hereinafter called the 'Board')

ii. “The members constituting the Board shall not be more than Thirty Three out of which One member shall be from Founder member, eight members shall be from Patron members including patron members described under 10 (c) above, up to thirteen members shall be Donor members, and up to eleven members shall be Honorary members. Of these eleven Honorary members, Six members can be elected from amongst the Ophthalmic consultants and Senior Executives permanently employed by MRF and scientists permanently employed by Vision Research Foundation, and the balance five Honorary Members not employed by MRF. As far as M/s Jaslok Hospital and Research Center is concerned they are entitled to nominate two persons to the Board of Management. The persons nominated by M/s Jaslok Hospital and Research Center, M/s John Fowler Ocular Lenses Private Limited., M/s Jamwadi Investment Trading (P) Ltd, Sir Ratan Tata Trust, Essel Mining and Industries Limited, Kolkata are entitled to be elected as members of the Board of Management as stipulated under clause 10(c) of the bye laws”

16. MEETINGS & RESOLUTIONS:

I. The President shall preside at the Board Meetings and in his absence the Vice President. In the absence of both, a Chairman shall be elected from among the members present in person or through any of the available video conferencing to conduct the proceeding of the meetings

PROPOSED CLAUSE

7


G. RAMACHANDRAN

Honorary Secretary & Treasurer

Important Note: Dear Members, We request you to kindly share your email ids & phone numbers for the current and future meetings so

that we will be able to send an e-invite/link to the same id as the meeting will be held online due to the prevailing

Covid pandemic situation. Kindly send the same to Ms. Akila Ganesan – Director Administration, Medical Research

Foundation [email protected] / [email protected] with your name & company’s name at the earliest.

18. GENERAL:

The Research Centre Hospital - Sankara Nethralaya, of the Medical Research Foundation shall provide diagnostic and treatment facilities to all without distinction of caste, creed race, religion or language but also

(a) free to at least 40 per cent of all their out-door patients:

(b)free to all inpatients belonging to families with less than monthly income of Rupees Three thousand five hundred or any other income limit which may be decided by the Board from time to time, keeping for this purpose at least fifteen percent of all the bed reserved for such patients

EXISTING CLAUSE

18. GENERAL:

The Research Centre Hospital - Sankara Nethralaya, of the Medical Research Foundation shall provide diagnostic and treatment facilities to all without distinction of caste, creed race, religion or language but also

(a) free to at least 40 per cent of all their out patients:

(b)free to all inpatients belonging to families with less than monthly income of Rupees Twelve Thousand or any other income limit which may be decided by the Board from time to time, keeping for this purpose at least fifteen percent of all the bed reserved for such patients

PROPOSED CLAUSE

8

SANKARA NETHRALAYA

PHILOSOPHY

The mission of Sankara Nethralaya is to

provide Total Eye-care solutions of highest

standards to all sections of community through

a team of competent, committed and

compassionate professionals in a patient-

friendly environment.

Sankara Nethralaya is also committed to

create a CENTRE of Excellence for ophthalmic

professionals for continuously updating their

knowledge through Education, Training, and

carrying innovative India centric Research to

benefit the entire ophthalmic community.

In all our undertakings we will be guided by the

underlying philosophy of Sankara Nethralaya.

Let the word Sankara of Sankara Nethralaya

ever remind me and my associates His Holiness'

command that there be a missionary Spirit in

the project.

Let the word Nethralaya constantly remind me

and my colleagues that the place of our work is

an Alaya. Work will be our Worship which we

shall do with sincerity, dedication and utmost

Love

We pledge to meet the patients' requirements

by offering expert ophthalmic care with

compassion through a committed professional

team.

We commit to achieve Continual quality

improvement to our services through the

Quality Management System while complying

with all applicable regulatory requirements.

QUALITY POLICY

Ongoing care and concern for maintaining

high level of staff satisfaction and

motivation.

To maintain the quality of ophthalmic

services in accordance with international

standards.

Effective utilization of infrastructure

facilities including manpower.

To ensure continued patients' satisfaction.

QUALITY OBJECTIVESMISSION STATEMENT


9

BOARD OF MANAGEMENT 2019 - 2020

President Dr. Girish S. Rao

Honorary Secretary & Treasurer Mr. G. Ramachandran

Other Members of the Board

1. Dr. Ananthkumar Badrinath Member

2. Mr. Ashok Kumar Mehta Member

3. Dr. Badrinath S.S. Member

4. Mr. Jagdish M. Chanrai Member

5. Mrs. Mallika Srinivasan Member

6. Mr. Mani. S. Subramonian Member

7. Mrs. Nina B.H. Kothari Member

8. Mr. Parekh R.C. Member

9. Ms. Prabhavathy Seethapathy Member

10. Mr. Ramakrishna C. Member

11. Dr. Ramasami T. Member

12. Mr. Rajaratnam S. Member

13. Ms. Rajashree Birla Member

14. Mr. Raju Barwale Member

15. Mr. Sirish R. Barwale Member

16. Mr. Sugalchand Jain N. Member

17. Dr. Surendran T.S. Member

18. Dr. Saravanan M. Member

19. Mr. Taraporevala B.S. Member

20. Dr. Usha Zehr Barwale Member

21. Mr. Vaidyanathan V. Member

22. Dr. Vasan K.S. Member


10

President & Medical Director Administration

Managing Director

:

:

Dr. Girish Shiva Rao

Dr. K. S Vasan

Director Administration : Ms. Akila Ganesan

Deputy General Manager (Finance) : Ms. Susila Girisan

Auditors : M/s. S. Viswanathan, LLP

Chartered Accountants, Chennai

Bankers : HDFC Bank Ltd., State Bank of India

Registered Office : Old No.18, New No.41, College Road,Chennai - 600 006.

Main Hospital

Jagadguru Kanchi Sri Chandrasekarendra

Saraswathi Nethra Nilayam

Dr. V. G. Appukutty Campus,

C.U. Shah Sankara Nethralaya &Jaslok Community Ophthalmic Centre.Academy - Elite School of Optometry,The Sankara Nethralaya Academy

Navasuja Sankara Nethralaya

Smt. T. K. Lakshmi Ammal and Smt. T.K.

Alamelu Ammal Sankara Nethralaya

Old No.18, New No.41, College Road, Chennai-600006.

21, Pycrofts Garden Road, Chennai 600 006.

No.8, GST Road, St. Thomas Mount, Chennai 600 016.

No.73, VenkataKrishna Iyer Road, Raja Annamalaipuram, Chennai 600028.

New No 39. Old no. 19, 1st Main Road,

East Shenoy Nagar, Chennai 600 030.

Suraj Sankara NethralayaNo. 34, Dharmaraja Koil Street, Chetpet Post & Taluk, Tiruvannamalai Dt, Pincode 606801

Locations of Sankara Nethralaya:

Sri Srinivasa Sankara Nethralaya

Sri City Sankara Nethralaya

Central Hospital, K.T. Road (Near TTD Administration Bldg.) Tirupathi 517 501.

Sri City Medical Care Center,

305, North, 2nd street, Sector3,Sri City, Varadaiahpalem Mandal, Chittoor Dist, AP - 517541.

Tamil Nadu

Aditya Birla Sankara Nethralaya

Sankara Nethralaya RSM Square

No.147, Barakhola, Mukundapur, E M Bypass, (Near

Santhoshpur Connector Kolkata - 700 099.

No.10, Raja Subodh Mallik SquareKolkata - 700013

Premises No.25-3333, Plot No. D J 16, Action Area – 2, Kolkata - 700156

Kamalnayan Bajaj Sankara Nethralaya

Andhra Pradesh

West Bengal


11


ANNUAL REPORT FOR THE FINANCIAL YEAR 2019-20

I have great pleasure in presenting the 42nd Annual Report of the Medical Research Foundation.

FINANCIAL PERFORMANCE

The financial performance of the Foundation for the year 2019-20 is summarized below:

Description 2019-20 2018-19

INCOME

Hospital Collections 20736 20763

Grants and Other Income 2464 2474

Total Income

EXPENDITURE 22062 21431

Surplus before Depreciation 1138 1806

Depreciation 1841 1737

Net Surplus/Deficit (703) 69

23200 23237

(Rs in Lakhs) (Rs in Lakhs)

The Hospital Collection this year was almost equivalent compared to 2018-2019. Due to

COVID-19 pandemic, hospital was not in operation from 26th March 2020, which has affected

the functions of the Foundation hence the growth in Income was not seen.

After meeting all the expenses including depreciation, Net Expenditure over Income was Rs. 703 lakhs compared to the Net Income over Expenditure of Rs. 69 lakhs of 2018-19.


12

Donations

Fixed Assets

(Rs in Lakhs)(Rs in Lakhs)

CASH FLOW

Description 2019-20 2018-19

Source

Add: Depreciation

Cash flow from operations

1841

(703)

1737

69

Donations 3033 1912

Increase / Decrease In Current Liabilities

ICICI KfW loan for St Thomas Mount

829

750

(266)

750

Total Sources 5750 4202

Investment - Capital expenditure 1990 850

Investment - Project (St. Thomas Mount) 1367 1059

Mukundapur Lease payment / RA Puram Land & Building

427 613

ICICI Technology loan – Repayment 608 500

Cash Surplus/(Deficit) 1358 1180

Opening Cash Balance 8377 7197

Total Applications

Closing Cash Balance

4392

9735

3022

8377

Applications

Donations received during the year amounted to Rs. 3033 lakhs. The corresponding figures for 2018-19 were

Rs.1912 lakhs. Major grant received from H T Parekh Foundation for Rs.1495 lakhs.

An amount of Rs 1849 lakhs for updating technology & replacements. An amount of Rs 141 lakhs is spent

towards EDP/Software and also an amount of Rs 1367 lakhs spent towards New Community Hospital - St.

Thomas Mount.


13

OPERATIONAL PERFORMANCE

YEAR 2019-20

OUTPATIENT CONSULTATION 841187 870450

MAJOR OUTPATIENT PROCEDURE 125992 127765

SURGICAL PROCEDURE 60160 63905

2018-19

DESCRIPTION NUMBERS

Treatment of Poor Patients

DEPARTMENT ACTIVITIES

EYE BANK

The number of free surgeries in the FY 2019-20 was 21017 against 22810 in FY 2018-19. Number of free

surgeries as a percentage of total surgeries done was 35% in the FY 2019-20 and 36% in the FY 2018-19. The

revenue foregone through free services and waiver / concessions amounts to Rs.4368 Lakhs. Last year the

corresponding amount was Rs.4324 lakhs.

The reason for the slight decrease in the free surgeries is due to the closure of the Community Theatre for

significant period of days in March 2020 due to COVID-19 pandemic lockdown.

"The Details of Corneal Transplant services during the period April 2019 – March 2020 are as follows:

1. Total Number of eyes Collected: 1372 numbers against 1012 numbers in 2018 - 19

2. Total Number of Corneal Transplant surgeries performed: 656 numbers against 677 numbers in 2018-19

3. Amount Received from Reliance Dhristi Project towards performance of free corneal transplant:

Rs. 2,02,500 (Rs. Two Lakh two thousand five hundred only)” pending amount 4,57,500. (Rs. four lakh

fifty seven thousand five hundred only)

4. Amount received as Grant from NPCB (National program for control of blindness) during the Period Rs.

11,53,000 (Rs. Eleven lakh fifty three thousand only)


14

1. Clinical & Managerial Quality Indicator Meeting with the top Management –

conducted every month.

2. Patients feedback analysed and presented to the stakeholders and the top

management

3. Patients complaints sorted within the timelines.

4. SOPs updated as per NABH norms for all the 6 centers.

5. CUSHAH’s accreditation status transited from Small Healthcare Organization to Eye

Care Organization

6. Internal Audits conducted for all centers

7. Mandatory training is carried out as per the NABH standards for the SN employees

and the out sourced employees.

8. The required data for NABH sent in appropriate periodicity for all centers.

II. Quality Activities carried out until lockdown:

I. NABH Accreditation Status for Entire SN

Sl. No SN Location Certificate validFrom To

Last Audit Date AccreditationStatus

1 SN Main Campus 20/12/2018 - 19/12/2021

2 JKCN 18/02/2018 - 17/02/2021

03/12/2019 - 02/12/20223 CU SHAH-ECO

4 NSN 20/12/2018 - 19/12/2021

5 RAJARHAT-SNKKamalnayan Bajaj SN

27/07/2019 - 26/07/2022

6 Aditya Birla SN 29/04/2019 - 28/04/2022

24th & 25th Feb’2018 Valid

18th,19th & 20th Sep’2017 Valid

7th & 8th June’2019 Valid

18th & 19th Aug’2018 Valid

23rd &24th Feb’2019 Valid

3rd & 4th Nov’2018 Valid


SN takes pride in leveraging its investment in Information Technology & Systems. The

technology investments have enabled SN to drive operational improvements in its business

operations, improve efficiency besides sustainable patient care.

IT & Systems

15

We are focused on providing highly resilient and trusted technology environment to sustain

a technology driven business support to our entire operations. We have now a completely

digitally enabled campus across most of our locations giving us capabilities to launch newer

solutions for our internal users.

Cyber security continues to be a bigger threat to provide a trusted IT environment for our

users. We have been proactively managing the cyber security threats. We continuously

monitor cyber security threats and keep a close watch on cyber security trends across the

industry. Our Cyber warriors are active participants in cyber forums and learn and exchange

best practices in cyber defense and have evolved cyber tactics to meet our specific needs.

Our data stored in our servers, networks and end points are continuously hardened against

any known vulnerabilities and we continue to take proactive measures to defend against any

targeted or unknown cyber-attacks.

An attempt is being made to develop the next generation of smart storage solutions for

medical imaging. Coupled with AI driven solutions could transform the needs of EMR for

enhanced decision making. A beta solution is under review.

The SD WAN solutions developed in house continue to be under beta in view of network

changes in various locations and are fine tuned for performance and diverse needs. We have

seen positive results and will be rolled out progressively in major locations in the coming

year.

SN IT has been collaborating with users to address their business needs to bring in innovation

in their business processes and to provide improved operational efficiency in patient care.

The engagements pursuits had resulted in enhancements to the HMS / EMR software.

As part of our technology modernization program we have rolled out the SN-HMS-EMR into

the current technology stack provided by Microsoft resulting in the following major

benefits.

1. Enhanced data security

2. Multi browser support – leading to mobile compatibility for core applications

3. Cloud enablement for scale and agility

4. Enhanced application performance

With the new release, it gives us the ability to integrate our services through seamless

integration leveraging API services and bringing in transformation in how we can consume

advanced digital capabilities provided by the Cloud and Specialized AI service providers.

IT Infrastructure

EMR & Hospital Management solutions


16

Over the last one year we have rolled out new capabilities to our IT solutions. The areas of

changes include the following:

Ø Development of 100 + productivity tools to address application support and enabling

users to manage their own needs.

Ø Continued enhancements to EMR

Ø Continued focus on enhancing operational efficiency in the administration systems in

many areas which include Patient Billing, Insurance management, Optical, Central

stores, Patient services, Patient services for Patient feedback and related reports and

dashboards.

Ø Worked closely with Finance teams to develop new capabilities for audit and

compliance and Corporate billing.

Ø Additional automation areas include improved work flows, automated data capture,

patient tracking systems for time management, e-way bill systems for stock transfers

and many more.

Ø Enabled HR with smart internal tools significantly reducing end of the month processing

for attendance and payroll processing.

Ø Many of the key processes has been integrated with automated SMS, email alerts and

exception driven reporting.

Ø Service calls had been continually being reviewed proactive updates have been made to

provide users with self-help capabilities and tools for improved decision making while

servicing patient requests.

Ø SN IT teams had been closely working with Google global development teams and

engaged in developing new capabilities leveraging AI for Diabetic retinopathy,

glaucoma and Retina.

4. Fund Raising activities SN OM Trust Awarded Highest Award by Charity Navigator

In September 2019, the SN OM Trust Inc USA, a leading Indian

charity since 1988 and fund raising arm of Sankara Nethralaya

was accredited as a 4 star charity by “Charity Navigator”, the

highest rating for non-profits in the country. 'Charity

Navigator’ is USA's leading assessment organization, which helps donors make well informed

decisions and enables charities to exhibit their operational efficiency, compliance of norms

and commitment to best utilization of donor dollars.


17

In 2019, Sankara Nethralaya entered the

Microsoft Give campaign, wherein

Microsoft matches 100% of donations and

volunteer hours by employees to promote

philanthropy across the organization. The

Microsoft Give program generated around

25K, which in turn funds around 380

surgeries for patients with curable

blindness. Sankara Nethralaya Seattle-

Wash ington t rus tees Vi shwanath

Manchikalapati & JayaKiran Pagadala ex-Microsoft employee) helped organise a poker event

in support of the Give Campaign. Bala Reddy Indurti (President) also attended to support the

campaign.

The SN OM Trust organized an evening of

entertainment by “Drishti” at the

‘Infinite Energy Center’ Atlanta, USA on

8th September 2020. The event raised

$200,000 to support 3000 poor visually

challenged patients. Atlanta Trustee Srini

Reddy Vangimalla, Vice President

Moorthy Rekapalli & President Bala Reddy

Indurti addressed the audience about

Sankara Nethralaya fundraiser events in different cities in USA and service activities in

India.

The fund raising team led by SN OM Trust President Bala Reddy, Indurti Moorthy Rekapalli,

Srini Reddy Vangimalla, Rajasekhar Reddy Aila, Meher Lanka, JayaKiran Pagadala, Padmaja

Kelam, Upendra Reddy Rachupally, Ramesh Chaparala, Rajeev Menon, Suresh Vemulamada

& Neelima Gaddamanugu was responsible for raising such a huge amount to help the needy

in India. Bala Indurti dedicated this victory to Atlanta Chapter founder Dr. Seshu Sarma.

Sankara Nethralaya Seattle Chapter raises 25K with Microsoft Give

SN OM Trust Atlanta Chapter raises $ 200k to support 3000 poor blind patients


18

Not only did a grieving widower, Mr. MSS Raghavan

contributed a cheque towards setting up an

optometry room at the Sri A. Sivasailam Block in his

late wife, Mrs Komala Raghavan’s memory. He has

also bequeathed his house, where he spent his

happiest years, to Sankara Nethralaya, a deeply

touching and most unexpected benevolence.

Widower Donates in Wife’s Memory


Major CSR supporters in Financial Year 2019-20

1. M/s. Bharat Petroleum Corporation Ltd

2. M/s. Blue Cross Laboratories Pvt Ltd, Mumbai

3. M/s. Computer Age Management Services Pvt Ltd, Chennai

4. M/s. HDB Financial Services Limited, Mumbai

5. M/s. H T Parekh Foundation, Mumbai

6. M/s. The Clearing Corporation of India Limited, Mumbai

7. M/s. Kansai Nerolac Paints Limited, Mumbai

8. M/s. Standard Chartered Global Business Services Private Limited, Chennai

9. M/s. Star Health and Allied Insurance Co.Ltd., Chennai

10. M/s. Safina Towers Pvt Ltd., Bangalore

11. M/s. Universal Comfort Products Limited, Uttarakhand

12. M/s. L & T Technology Services Pvt Ltd, Chennai

13. M/s. Bharat Heavy Electricals Ltd., Chennai

14. M/s. VLS Capital India Pvt Ltd, New Delhi

15. M/s. Genpact India Pvt Ltd, Haryana

19

Major CSR supporters in Financial Year 2019-20


Sl. No Name of the company Supported Since

Supported for

1. M/s Computer Age Management Service Limited

2002 Free Cataract and complicated major surgeries.Eso Occupational Optometry Eye Examination

2. M/s Bharat Petroleum Corporation Ltd

2020 Community hospital – Equipment and naming an Operation Theatre

3. M/s HDB Financial Services Limited

2018 Rural camps, Cataract surgeries, Bus, Equipment, New community hospital building project

4. M/s The Clearing Corporation Of India Ltd

2017 MESU, Equipment, Major surgeries, SNEHAM project

5. M/s Standard Chartered Globalbusiness Services Pvt Ltd

2004 Teleophthalmology Camps, Cataract surgeries, MESU, Equipment, Bus, Spectacles

6. M/s Larsen And Toubro Ltd 1980 Naming a Department, Teleophthalmology, MESU

7. M/s H T Parekh Foundation 2015 Complicated free major surgeries, Equipment, Community Operation theatre in Kolkata, MESU, Ocular Oncology Centre Kolkata, COVID 19 Safety items

20

The Sri Srinivasa Sankara Nethralaya (SSSN) which was established in the year 2009 by Sri

Srinivasa Sankara Nethralaya Trust by Tirumala Tirupati Devasthanams (TTD). This center

has screened more than 10,665 new patients and has performed 3,503 cataract surgeries

during the financial year 2019 - 20 (FY 2018 -19: 11,983 new patients and 4,210 surgeries).

Mission for Vision Trust is playing a major role in mobilizing patients for free cataract

surgeries at SSSN.


AWARD AND RECOGNITION TO OUR FOUNDER & CHAIRMAN EMERITUSDR. S. S. BADRINATH

SANKARA NETHRALAYA’S SERVICE AT TIRUPATI THROUGH SRI SRINIVASA SANKARA NETHRALAYA

The Employee’s strength as on 31st March 2020 is 1583 (31st March 2019 was 1560)

Particulars As on 31.03.2020 As on 31.03.2019

Consultants * 154 153

Executives & Optometrists 535 552

Staff 894 855

TOTAL 1583 1560

*Includes Ophthalmologists, Physicians and Anesthetists

HUMAN RESOURCES AND DEVELOPMENT

The Human Resources Department carried out its function of recruitment, orientation for

new recruits, assessment of employee health and safety and implementing welfare

measures as per Institutional policy. The performance appraisal of the employees was

carried out through the metrics of Rubrics.

Training programs were conducted throughout the year. The training modules were

classified into Technical programs, sessions on soft skills and the mandatory sessions that

are required as part of NABH compliance.

"The Most Admired Gandhian of Tamil Nadu Award" by Senior Citizens Group of Besant Nagar

on 1st November 2019 at Chennai.

21

1. Aditya Birla Sankara Nethralaya & Kamalnayan Bajaj Sankara Nethralaya, Kolkata, West Bengal:

2. Sankara Nethralaya, Sricity, Tada, Andhra Pradesh:

3. Suraj Sankara Nethralaya, Chetpet, Tiruvannamalai District, Tamil Nadu:

(i) Aditya Birla Sankara Nethralaya, Kolkata, West Bengal:

This center has screened more than 61,820 new patients and performed 5,570 surgeries

during the financial year 2019 - 20. (FY 2018 -19: more than 75,773 new patients and 9,578

surgeries). It provides comprehensive eye care under one roof along with diagnostic and

therapeutic treatment facilities and acts as a regional referral center for patients from

North Eastern region of India. We have a dedicated team of 18 medical professionals and

179 non-medical support team along with 77 outsourced personnel to manage this center.

We are happy to share with you that this center was recently accredited with NABH

certification under Eye Care Organization standards.

(ii) Kamalnayan Bajaj Sankara Nethralaya, Kolkata, West Bengal

This center has screened more than 43,963 new patients and performed 7,856 surgeries

during the financial year 2019 - 20. (FY 2018 -19: more than 39,099 new patients and 5,630

surgeries). This center has facilities to provide comprehensive eye examination along

with top class facilities for all diagnostic and therapeutic treatment modalities. This

center is managed by a dedicated team of 12 medical professionals along with 131 non-

medical support team and 78 outsourced personnel. We are happy to share with you that

this center too was recently accredited with NABH certification under Eye Care

Organization standards.

Our center at Sri City, catering to the needs of industrial workers and also the needs of the

villagers living around this upcoming industrial town, has rendered services to more than

5,856 patients and has performed 84 cataract surgeries during the financial year 2019 – 20

Suraj SN assumes great importance as it would be dispensing world class eye care in a semi

urban region and serving a large number of indigent patients from the neighboring

villages, who do not have access to quality eye care. This center has screened more than

5,870 new patients and has performed 458 cataract surgeries during the financial year

2019 - 20 (FY 2018 -19: 3,358 new patients and 73 Cataract surgeries). In the land mark

year 2020, Sankara Nethralaya initiated a unique program SNEHAM 2020, to mark the

150th Birth anniversary of Mahatma Gandhi and the World Sight day. Combining the

visionary dream of Mahatma for villages, this project envisions equitable comprehensive

eye care to the rural villages. This scheme aims at providing 20/20 vision to every citizen

in 150 villages of the district of Tiruvannamalai.


ABOUT OTHER CENTRES OF SANKARA NETHRALAYA

22

CONCLUSION

Financial Year 2019 – 2020 saw the Foundation stepping into its’ 42nd year of Service to our

country. Under the inspiring and visionary leadership of Dr. Badrinath, the year saw the

Foundation embarking on new projects and expansion of its services besides setting a new

record in financial performance and a new record in number of free services performed.

True to its founding principle, the Foundation showed growth in all its areas of activity -

World class eye care, Community Services, Research and Education – broadly recognized as

the four pillars of the Foundation.

The year brought in a new President of the Foundation – Dr. Girish S. Rao – who assumed the

mantle of President with the blessings and approval of his mentor Dr. S. S. Badrinath and the

Board members. An Ophthalmology student of Sankara Nethralaya, Dr. Rao brings in both

clinical experience and Administrative experience to the job. With the resignation of Hony

Treasurer, I took over the additional charge of Hony. Treasurer till a new person is elected.

The Hospital Collection this year was almost equivalent compared to 2018-2019. The impact

of the pandemic was seen from the 3rd week of February, with patient flow reduced to 50%

from the 1st of March. Both out-patient and in-patient services were affected and should a

sharp decline for the month of March 2020. With the lockdown being announced, the

hospital was closed and not in operation from 26th March 2020, which has affected the

functions of the Foundation hence the growth in Income was not seen. After meeting all the

expenses including depreciation, Net Expenditure over Income was Rs. 703 lakhs compared

to the Net Income over Expenditure of Rs. 69 lakhs of 2018-19.

The hospital has been functioning throughout the lockdown offering emergency as well as

regular outpatient and inpatient care to both paying and free patients.

2019-2020 proved a record year for donations. Donations received during the year

amounted to Rs.3033 lakhs. The corresponding figures for 2018-19 were Rs.1912 lakhs.

Major grant received from H T Parekh Foundation for Rs.1495 lakhs helped in the

upgradation of the cataract operation theaters in all SN centres – both Chennai and Kolkata.

Further, HTP Foundation supported the construction of the new Academic block in VG

Appukutty campus to house The Sankara Nethralaya Academy. Large grants / donations

were also received from the Clearing Corporation of India, HDB Financial Service, Bharat

Petroleum and L&T Technology Services. SN OM trust also had a good donation drive.

With clinical work, academics and research marching ahead with full speed, 2019-2020 was

a busy and productive year for the organization.

Due to the prevailing pandemic situation, Sankara Nethralaya, who has always been an

innovator and pioneer in eye care, reached out to its patient base through Tele-counselling

and Tele-consultation. A tie-up with Titan Eye plus has been initiated to reach out to

patients across the country who are currently unable to travel to Chennai or Kolkata for

expert advice and care.


23

During the year, 60 Ophthalmologists got trained through the various Ophthalmology post

graduate and fellowship programs. In total 2282 Ophthalmologists have been trained by

Sankara Nethralaya. This is a proud achievement of the institution and reaffirmation of the

Vision of Dr. Badrinath. Further, another 150 students graduated from different programs

including Optometry, Medical Laboratory Technology, Business Administration, Nursing and

Ophthalmic Dispensing. These are all indicators of the robustness of Sankara Nethralaya’s

academic activities.

Research work at Sankara Nethralaya has helped produce 2 Ph. D graduates this year. A

further 15 students are pursuing their Ph.D. Numerous projects in Optometry (Binocular

vision, Contact Lens and Myopia) and Ophthalmology (Dry eye, Keratoconus, Diabetic

Retinopathy and Glaucoma) are being carried out. A number of papers have been published

on the research outcome in peer reviewed Indian and International journals.

REACH – a school screening project supported by Orbis was completed this year. The 3-year

project helped to screen 3 lakh school children studying in Corporation and government

aided schools across Kanchipuram, Chennai and Tiruvallur districts. The unique feature of

the screening was inclusion of Binocular Vision Screening – the first of its kind in the world.

5% of the children required spectacles which were distributed through the project.

HUMAN RELATIONS:

The Founder, Dr S S Badrinath and Dr Vasanthi Badrinath are the real force behind this great

institution, continuously guiding and monitoring the progress of the institution in every

sphere. Their concerted actions in the continuous development of Consultants and their

professional management style with succession plans have started yielding results. Dr

Girish S. Rao, Medical Director – Administration & Vice-President, MRF has moved

comfortably into the role of heading the administration of the hospital under the guidance

of Dr. Badrinath. With the support of Chairman Emeritus and the Administration team, he is

working on managing the hospital functions. The Vice Chairman, Dr T S Surendran, Medical

Directors / Senior Consultants Dr. Prema Padmanabhan, Dr Pramod Bhende and Dr L Vijaya,

Dr J Biswas all share a common vision as that of the Founder, Dr S S Badrinath, which helps to

continue the successful functioning of the Organisation.

Quality administrative support is provided by Dr K S Vasan, the M.D., ably assisted by Ms.

Akila Ganesan, Director Administration and Ms Susila Girisan, DGM – Finance. The Board

Members continue to render their expert guidance to ensure the smooth functioning of the

Organization.

Our entire para medical and administrative staffs are an important link between the

patients and the institution. They ensure the smooth functioning of the Organization.

Regular training classes are being held to some of these groups.


24

The pandemic has affected the financial position of MRF in 2 ways: Decreased patient flow

and increased expenses due to the purchase and usage of COVID safety items.

Understanding the headwinds that the organization would face, the Management worked

diligently right from May 2020, to reduce the cost and increase the donation drive. Salary

cut was implemented from July 2020. Financial discipline over the last 6-7 years had helped

to create a strong rainy day fund of Rs. 97 crores. All these factors have helped in tiding over

this very difficult situation.

I record with gratitude the support of the dedicated Board of Management who despite their

other priorities have always come forward to advise the Institution whenever needed even

at very short notices.

Our auditors, since the beginning of this institution, M/s S. Viswanathan & co. are carrying

out their assignment as a service to a non-for-profit organization for a token compensation. I

record with appreciation the personal involvement of the partners Mr. Chella K Srinivasan

and Mr. R. M. Narayanan. The internal auditors M/s Profaids are also very dedicated in their

service to us. I thank them for their personal involvement in our case.

SWAN, the women auxiliary wing of our organization is continuing their good service to

Sankara Nethralaya. Their contributions to the welfare of indigent patients treated at

Nethralaya are praise worthy. I salute these dedicated ladies guided by Ms. Surekha Ben,

Mrs. Appukutty, Mrs. Haridas and many more.

Our bankers, HDFC and SBI, are very considerate in taking up our requests and delivering

their service very promptly to us. I thank them for their support.

At this juncture, I need to extend my sincere gratitude to our Major Donors during this

financial year – Clearing Corporation of India, HDB Financial Services, HT Parekh

Foundation, Tata Trusts, Computer Age Management Services Private Limited, Bhabani

Pigments Private Limited, Binaguri Tea Company Private Limited and the TVS Group. They

have supported the Community Services of Sankara Nethralaya through large grants and

donations. I would also like to extend my gratitude to the numerous other donors who have

been the pillars of support for our work.

I thank the following partners for our community work for their help in taking care of our

indigent patients - Mission for Vision, Sri Shridi Sai Trust, Sri Sai Darshan Trust and Lions Club.

G. RAMACHANDRANHony. Secretary & Treasurer


25

ACADEMICS

During the year 2019-20 , MCI , New Delhi has converted the Post Graduate Diploma in

Ophthalmology(2 years) course to M S Ophthalmology (3 years) Course. The course will start

from the academic year 2020.

Number of people trained by Sankara Nethralaya in Ophthalmology so far are:

A total of 2282 Ophthalmologists are trained

National Board of Examination, New Delhi has increased the seats for DNB (Post MBBS) and

DNB (Post Diploma) from 5 seats to 10 seats. (Each Programme has the capacity of seat 10

Numbers) during the year 2019-20 onwards.

DO : 107

DNB : 214

Ophthalmology Fellows : 1125

Advance Cataract Fellows : 783

PhD (Ophthalmology) : 03(Ph D from BITS University & The Tamilnadu Dr M G R Medical University)

B.S. Optometry : 676

M Phil Optometry : 112

MSMLT (BITS, PILANI) : 96

*PhD (Optometry) : 10PhD (Ophthalmology)

* Ph.D. (Microbiology, Biochemistry Genetics, Pathology) : 56 (Ph D from BITS, The Tamilnadu Dr M G R Medical University,Sastra University & Deakin University Australia)

FRCS Edinburgh : 50

During the year of 2019-2020 total number of PG’s ,fellows and others trained.

Total No of Students completed their Program

Ophthalmology Fellowship Programme : 40

Cataract Fellowship : 07

DO : 3

DNB : 7

Observer, other ophthalmology training : 3


26

THE SANKARA NETHRALAYA ACADEMY

The Sankara Nethralaya Academy, an academic wing of Sankara Nethralaya, offers distinct

programs in Allied Health Sciences at various levels. We strive to uphold the philosophy of

inclusive service to the community by making the quality education affordable for the

weaker segments of the society. We also extend hostel and mess facilities, either subsidised

or totally free, for the needy girl-students.

PROGRAMS OFFERED

l Affiliated to TN Dr.MGR Medical University

w M Optom

w MHA (AHS)

w MSc (Medical Laboratory Technology)

w BSc (Medical Laboratory Technology)

w Diploma in Optometry

l In collaboration with Periyar University

w BSc (Ophthalmic Dispensing &Vision Science)

l In collaboration with Hindustan Institute of Technology & Science (Deemed to be

University)

w MBA (Hospital & Healthcare Management)

w BBA (Hospital & Healthcare Management)

l In collaboration with ITM University, Raipur

w M Optom

FELLOWSHIP PROGRAMS

l Fellowship in British Dispensing Opticians from the Association of British Dispensing

Opticians, UK

l Work Integrated Fellowship in Clinical Optometry

l Fellowship in Clinical Optometry /Low Vision /Contact Lens /Binocular Vision /Vision

Therapy /Neuro Optometry /Ocular Prosthesis /Optical Dispensing (Basic)

SHORT TERM /DISTANCE PROGRAMS

l Continuing Optometry Education /Medical Education

l Post Graduate Program in Hospital Management /Optical Retail Management

l Certificate in Optical Retail Management /Hospital Infection Control /Hospital

Management /Hospital Finance Management /Hospital Quality Management


27

Highlights of the Year

l Shifted to our own premises at Dr.VG Appukutty Campus, St. Thomas Mount, Chennai, in November 2019, with enhanced facilities.

l Our students’ demographics is dominated by girl-students, to the extent of 85%.

l With the support from philanthropists, extended full /partial course-fee waivers for 30 students besides full /partial hostel /mess-fee waivers for 40 students

l Organized Corporate Training Program for 30 security staff of NLC India Ltd.

l Commenced the first batch of MOptom, offered in collaboration with ITM University, Raipur.

l 13 students completed FBDO (3 years program) during this year.

l First batch of BSc (OD) completed the course, out of which 13 students have been placed in Sankara Nethralaya.

l BSc (ODVS) (3rd and 4th year) students were part of over 50 REACH & SNEHAM camp conducted by SN/ESO. MOptom students played a major role in over 7/12 TTD camps conducted by ESO team.


28

Ø In SN-Kolkata, introduced Fellowship

programs in Optical Dispensing (Basic),

Clinical Optometry and WIFCO.

l Degree Certificates distribution ceremony

held in January 2020 for 42 students of

B.Sc (OD) and 15 students of B.Sc (MLT).

l Our students participated, and some of

them got prizes, in various seminars

/conferences /workshops /training

programs organized by different institutions /organizations.

l In the state level phlebotomy competitive exam conducted by Indian Association of

Basic and Paramedical Sciences, our

students grabbed all the three awards.

l As a part of our community service, our

students visited orphanages /senior

citizens homes for spending time with

their routine.

l Organized one day workshop on Getting

Employment by Choice Rather Than by

Chance for final year UG students of

various institutions.

l Organized Essay & Oratorical competition for XI & XII students on the eve of 137th

Birthday Anniversary of Mahakavi Subramanya Bharathiyar.

l 100% Results in the end semester examination conducted by Hindustan Institute of

Technology & Science (Deemed to be University).

l 100% Placement for outgoing students of MHA, MBA & BBA courses.

l Members of ROTARACT Club of TSNA, under the auspices of Rotary Club of Madras East,

participated in various community service programs, reaching out to those in distress.

l Binocular Vision Anomalies in Keratoconic Patients authored by Sushmitha AD was

published by the Optometry and Vision Science Journal of the American Journal,

American Academy of Optometry.

l COVID-19 Limiting the Risk for Eyecare Professionals was authored by Soumen Sadhu in

Ocular Immunology and Inflammation published by Taylor and Francis Group.


29

S.No. Candidates Name Title Supervisor Date of Viva-Voce Examination

1.

Educational Activity of

Vidyasagar Institute of Biomedical Technology & Science (VIBS)(JULY 2019- JUNE 2020)

I Ph.D. Programme:

1.Number of Ph. D. Awardees: - (July 2019 – June 2020) = 2(SASTRA Deemed to be University, Thanjavur – 2)

VIBS was established on 25th October 2006 to promote research including fundamental research and foster biomedical technology and science in Basic Medical Sciences.

Mr. Ravikanth Danda(ID No: PH 510)(Stem cell Laboratory)

Dr. S. Krishna KumarProfessor & HOD(L & T Ocular Pathology department & Incharge of Nano Biotechnology & Stem cell biology departments)

Prof .Usha Kim,Chief, Orbit, Oculoplasty and Ocular Oncology Services, Director

12th December 2019

“Identification of Novel therapeutic target molecules in Retinoblastoma”

a)Number of candidates obtained Ph.D from SASTRA deemed to be University, Thanjavur = 1

2. Mr. K.Anand Babu(ID No: PH 615)(R.S.Mehta Jain Department of Biochemistry & Cell biology)

Dr.AngayarkanniNarayanasamy(Professor & Head of R.S.Mehta Jain Department of Biochemistry & Cell biology)

Dr.K. DharmalingamDirector-Research, Aravind Medical Research Foundation, Madurai.

17th February 2020

"Role of paraoxonase in oxidized LDL – Mediated Pathogenesis of age related molecular degeneration (AMD): in vivo studies in AMD patients and in vitro studies in human retinal pigment epithelial cells”

ExternalExaminer


30


II) Ph.D Candidates (16 undergoing Ph.D. + 1 - in the process of submission of final thesis + 7 submitted Ph.D. Thesis) under 4 different National Universities:

S.No

1.

2.

3.

5.

4.

L & T. Ocular Pathology Department (N=5)

Nano Biotechnology Department (N=2)

SN ONGC Departmentof Genetics & Molecular Biology (N=6)

Centre for Bioinformatics (N=4)

R.S. Mehta Jain Department of Biochemistry and Cell Biology (N=7)

12

1-

13

21

24

2--

1--

-2-

-1-

--1

Basic Medical SciencesDepartments, KNBIRVO Block (N =24)

UndergoingPh.D. Programme(10)

Ph.D. Thesis submitted & awaiting viva (7)

In the processof Submission offinal thesis(1)

undergoingPh.D. Programme(3)

undergoingPh.D. Programme(3)

SASTRA Deemedto be University, Thanjavur (12)

Alagappa University, Karaikudi

Alagappa University, Karaikudi

Tamilnadu Dr.MGR MedicalUniversity, Chennai

2. A) No. of Candidates Submitted Ph.d Thesis & Awaiting Public Viva-voce: Sastra Deemed To Be University, Thanjavur: (N =7)

S.No. Candidates Name Title of Ph.D. Thesis Supervisor’s Name

1. Ms. Bhavna S Rao(ID No: PH 684)(SN ONGC Department of Genetics & Molecular Biology)

Dr.N. Soumittra(Faculty, SN ONGC Department of Genetics & Molecular Biology)

21st June 2019“Fuchs’ endothelial corneal dystrophy - genetic analysis using whole genome sequencing, association study and candidate gene screening”

2. Mr.R.N.Naresh kumar(ID.No: PH 718)(R.S.Mehta Jain Department of Biochemistry & Cell biology)

Dr.K. Coral Miriam(Faculty, R.S.Mehta Jain Department of Biochemistry & Cell Biology)

21st June 2019“Molecular mechanism of the anti angiogenic and anti tumorigenic potential of Lysyl Oxidase Propeptide (Lox-PP)”

Date of Final submission of Ph.D. Final thesis

31


S.No. Candidates Name Title of Ph.D. Thesis Supervisor’s Name

3. Ms. P. Karthikka(ID No: PH 528)(R.S.Mehta Jain Department of Biochemistry & Cell biology)

Mr.S.Muthukumaran(ID No: PH 719)(Centre for Bioinformatics)

Dr.C.Subbulakshmi(Faculty, Vision Research Foundation)

21st June 2019“Functional characterization of adiponectin in the molecular events preceding the onset of diabetic retinopathy”

4. Dr.V.Umashankar(HOD of Centre of Bioinformatics, Vision Research Foundation)

21st June 2019“Computational design, synthesis and validation of potential inhibitors targeting human Ornithine decarboxylase (ODC) to modulate polyamines in retinoblastoma cells”

5. Mr. Arun John(ID No: PHBIFE1504903)(Centre for Bioinformatics)

Dr.V.Umashankar(HOD of Centre of Bioinformatics, Vision Research Foundation)

2nd March 2020“In silico design of peptide and chemical inhibitors targeting carbonic anhydrase IX mediated pH homeostasis in cancer cell and in vitro validation of inhibitory efficacies”

Ms. Vidya Gopakumar(ID No: PH 511)(Stem Cell Laboratory)

6. Dr.S.Krishnakumar(HOD of L & T Ocular pathology Department, Incharge of Stem cell & Nanobiotechnology departments)

25th May 2020“Generation of corneal epithelial cells from noncorneal autologous source for the treatment of bilateral limbal stem cell deficiency”

Mr.Amit Chatterjee(ID No: PHBIOFE1404812)(Department of Nanobiotechnology)

7. Dr.J.Narayanan(Associate Professor Department of Nanobiotechnology)

4th June 2020“Understanding the mechanism of cell penetrating peptide using kerataconus epithelium as clinical model”

Date of Final submission of Ph.D. Final thesis

32

(ii) The Tamilnadu Dr. M.G.R. Medical University, Chennai: (N=1)

1. Ms. Rebecca Manohar(Reg. No. 141510008)(R.S.Mehta Jain Department of Biochemistry & Cell biology)

Dr.AngayarkanniNarayanasamy(Professor & Head of R.S.Mehta Jain Department of Biochemistry & Cell biology)

1st October 2018

23 S.No. Candidates Name Title Supervisor Date of

Draft Thesis submission

"Elucidating the disease mechanism associated with Elastogenesis in Pseudoexfoliation syndrome: An in vitro and ex vivo study”


IV. Master of Science (MS By Research) Programme: Number of Candidates Completed MS Programme in Research:(N=2)

S.No

1.

Candidate Name Topic Supervisor & Joint Supervisor

Registration Month & Year

Final viva voce

Mr.Ranjith kumar R(ID No: 17145281102)

Supervisor: Dr.Tamilselvan Asst.Professor, Centre for Biotechnology, Anna University, Chennai

Joint Supervisor:Dr.Sailaja V. ElchuriAssociate Professor, Dept., of Nano-biotechnology

January 2017 29th October 2019

“3D cancer tissue growth on graphene sponges for cancer drug therapy”

2. Mr. Hemanth R(ID No:17145281106)

Supervisor: Dr.Devasena T Associate Associate Professor, Centre for Nanoscience & TechnologyAnna University, Chennai

Joint Supervisor(Applied & awaiting communication)

Dr.S.Krishnakumar HOD L & T Ocular pathology, Nano-biotechnology Depts.

January 2017 November 2019

“Circulating exosomal miRNA in serum as biomarkers for Retinoblastoma”

S.No. Basic Medical Sciences Department No. of students (30)

1. L & T Microbiology Research Centre 6

2. R.S. Mehta Jain Department of Biochemistry & Cell Biology 8

3. Centre for Bioinformatics 4

4. SN ONGC Department of Genetics & Molecular biology 8

5. Department of Nano Biotechnology 4

33

V. OTHER EDUCATIONAL ACTIVITIES CONDUCTED AT VIBS :Short term Research Projects for PG students in Biological sciences:30 students underwent VIBS – Short term projects from “December 2019- March 2020” in the 5 Basic Medical Sciences departments, as part of their academic programme from 10 Engineering Colleges & 2 Arts & Science Colleges.

S.No. Basic Medical Sciences Department No. of students (5)

1. L & T Ocular Pathology Department 1

2. SN ONGC Department of Genetics & Molecular biology 1

3.

4.

L & T Microbiology Research Centre

R.S.Mehta Jain Department of Biochemistry & Cell Biology

1

2

VI. Specific Training programmes on specialized/advanced Techniques such as PCR/PCR RFLP, RT- PCR, ELISA, HPLC etc.(In the year July 2019 – June 2020)5 students underwent Special Training programme in the Basic Medical Sciences departments from 2 Arts & Science Colleges & 3 Engineering Colleges


34

Independent Auditor's ReportTo the Members of MEDICAL RESEARCH FOUNDATION for the year ended 31st March 2020.

Medical Research Foundation

Report on the Financial Statements

We have audited the accompanying financial Statements of MEDICAL RESEARCH FOUNDATION which comprises the Balance Sheet as at 31 March, 2020, and the Income and Expenditure account for the year then ended, and a summary of significant accounting policies and other explanatory information.

Management’s Responsibility for the Financial Statements

Management is responsible for the preparation and presentation of these financial statements that give a true and fair view of the financial position, financial performance of the foundation in accordance with the Accounting Standards. This responsibility includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the foundation and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

Auditor’s Responsibility

Our responsibility is to express an opinion on these financial statements based on/ our audit. We conducted our audit in accordance with the Standards on Auditing issued by the Institute of Chartered Accountants of India (ICAI). The Standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and the disclosures in the financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the foundation’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances but not for the purpose of expressing an opinion on whether the foundation has in place an adequate internal controls system over financial reporting and operating effectiveness of such controls. An audit also includes evaluating the appropriateness of the accounting policies used and the reasonableness of the accounting estimates made by the management, as well as evaluating the overall presentation of the financial statements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Emphasis of Matter

Impact of COVID-19:

(a) We draw attention to Note: IV of the financial statements, which describes the effect of COVID-19 pandemic. The Hospital was not in operation from 26th March 2020, which has marginally affected the functions of the foundation.

It is not appropriate to estimate the duration and severity of these consequences, as well as their impact on the financial position and results of the foundation for future periods.


35

Independent Auditor's Report(b) Due to Covid-19 related lockdown, we wee nrot able to physically observe the

physical verification of inventory that was carried out by the management at the year end. Consequently, we have performed alternate procedures to audit the existence and condition of inventory as per the guidelines provided in SA 501 “Audit evidence -Specific consideration for stipulated items’, which includes inspection of supporting documents relating to purchases and sales to issue our unmodified opinion on the financial statements.

Debtor’s confirmation:

In the case of sundry debtors, we have not been provided with the confirmation of balance from debtors and hence unable to comment over it.

Our opinion is not modified in respect of above matters.

Opinion

In our opinion and to the best of our information and according to the explanations given to us, the financial statements give the information required by the act in the manner so required and give a true and fair view in conformity with the accounting principles generally accepted in India.

a) In the case of the Balance Sheet, of the state of affairs of the Foundation as at March 31, 2020.

b) In the case of Income and expenditure account, of the Excess of expenditure over income for the year ended on that date.


For M/s. S.VISWANATHAN, LLP Chartered Accountants

Regn No.: 004770S / S200025

Chella K. SrinivasanPartnerMembership No.:023305

Place : Chennai Date : 26.09.2020

36

stBALANCE SHEET AS AT 31 MARCH 2020

AS AT 31.03.20 AS AT 31.03.19PARTICULARS

Rs. Rs. Rs. Rs. LIABILITIES

CORPUS FUND

DONATION u/s 35ACAs per Last B/S 272906563 272906563

272906563 272906563

SIR RATAN TATA TRUST CORPUS FUND SRTT CORPUS FUND 65834003 65052186 MRF CORPUS FUND 54546664 120380667 53926957 118979143

GENERAL FUND I 2558494730 2316844816

EARMARKED FUNDS II 9881341 2077982

NON CURRENT LIABILITIESICICI TermLoan (TI-Project) 239200000 225000000Gratuity Liability 109854400 88254763Leave Encashment Liability 87860691 436915091 74421443 387676206

Current Liabilities & Provisions III 201926283 191044425

TOTAL LIABILITIES 3600504675 3289529135

ASSETSFIXED ASSETS IVGross Block As on 31.03.2020 3989926864 3521110120Depreciation 2037682594 1853541101Net Block

Fixed Assets not put in use

1952244270 1667569018

Capital Work in Progress - 89344590

Net Fixed Assets as on 31.03.2020 1952244270 1756913609

Investments V 410623409 405136425

Current Assets VI 1237636996 1127479101

TOTAL ASSETS 3600504675 3289529135

SCHEDULE

We declare that the particulars furnished above are true and correct to the best of our knowledge and belief.

Examined and found correct as per the books maintained

by Medical Research Foundation (Regd.) Chennai.

M/S. S. VISWANATHAN, LLPChartered Accountants

Regn, No. 004770S/S20002517, Bishop Wallers Avenue (west)C I T Colony, Mylapore, Chennai 4 DATE : 26.09.2020

RAMACHANDRAN G.Hony. Secretary & Treasurer

DR. GIRISH S. RAOPresident

AKILA GANESANDirector - Administration


CHELLA K. SRINIVASANPartner M.No. 023305

INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31.03.2020

PARTICULARS

Rs. Rs.INCOME SCHEDULE

Hospital Collections 2073555675 2076351715Non Corpus Donations 48804999 53331818Grants 17076359 22815377Interest 95816719 77794512Other IncomeResearch Income

6622814618555935

7376481919668901

TOTAL 2320037833 2323727142

EXPENDITURE

Hospital ExpensesSalaries, Wages & Employee Benefits

VIIIVII

1007994955952937014

1015284293884360131

Administration Expenses IX 225338116 234561569Interest X 5292444 2228357Research Expenses XI 14621997 6683335

TOTAL 2206184526 2143117684

Surplus before Depreciation 113853307 180609458

DEPRECIATION 184141492 173749171

EXCESS OF EXPENDITURE OVER INCOME 70288185 (6860287)

31.03.2020 31.03.2019

37


We declare that the particulars furnished above are true and correct to the best of our knowledge and belief.










Rs. Rs. Rs. Rs.SCHEDULE 1

GENERAL FUND

As per Last B/S 2316844816 2045565855

Less : Amount transferred to Earmarked Fund 4296774 1386000

Add : Amount transferred from Earmarked Fund

Add : Donations received during the year

Add : Excess of Income Over Expenditure

Less : Excess of Expenditure Over Income

1500000

314734873

70288185

50000000

215804673

(6860287)

Total General Fund 2558494730 2316844816

SCHEDULE II

EARMARKED FUNDS

Sir Ratan Tata - Phase III 30962 30962

SN Mahema Devadoss Endowment Fund 6750000 1266373

Sri Ramdoss Bhavani Nethralaya Endowment

Subramanyam G Endowment Fund

100000

1000000 1000000

100000

Dhingra Family Trust - Fund

Trent Ltd

1000000

-

1000000

1500000

Dr. Nirmalasubramaniam Endowment Fund

Orbis Project

254000

(1544747)

254000

762111

Dr. Raja Gopal Endowment Fund 132000 132000

Navajbai Ratan Tata TrustMRF Limited

Renuka Devi Endowment Fund

Sivasankari Chandrasekaran Endowment Fund

(1340874)2500000

500000

500000

(6467464)2500000

-

-

Total Earmarked Funds 9881341 2077982

SCHEDULE III

CURRENT LIABILITIES & PROVISIONS

Sundry Creditors - Suppliers 136200863 132980276

Sundry Creditors - Bills payable 15456056 12356862

Sundry Creditors - (Deferred Payment) 6891412 12228601

Salary Payable 3144312 4504186

Security Deposit - Others 20000000 20000000

Employees Benefit /Contingency/ Common Good Fund

8570297 2392255

Others 11663343 6582245

Total Current Liabilities & Provisions 201926283 191044425

stSCHEDULES TO BALANCE SHEET AS AT 31 MARCH 2020

38


39

MED

ICA

L R

ESEA

RC

H F

OU

ND

AT

ION

FIX

ED

ASSET

S

%

Cos

t Va

luat

ion

as a

t 0

1.04

.19

Addit

ions

2019-2

0

Del

etio

ns

as a

t 31

.03.

2019

Dele

tions

Du

ring

the

Year

201

9-20

Dele

tions

Till

31.0

3.1

9

GRO

SS B

LO

CK

as

at

31.0

3.2

0Addit

ions

2nd H

alf

Addit

ions

1st

Half

Rs.

Rs.

Rs.

Rs.

Rs.

Rs.

Rs.

Rs.

Rs.

Rs.

276402530

-10896100

10896100

1002875

1002875

286295755

-

-

-

- -

LEASE

HO

LD

PRO

PERTY

685277

27740936

2222847

29963783

-

-

-

-

-

30649060

342615

-342615

275399655

5%

1053415155

-178990995

178990995

6645483

6645483

1225760667

329313172

40347600

369660772

717456500

EQ

UIP

MEN

TS

& IN

STRU

MEN

TS

20%

1372439859

41181193 -

110177984

18061128

151359177

1476714

9143104

10619818

1513179218

968134597

97991125

1066125723

402828548

PLAN

T &

MACH

INERY

15%

113361441

18061128

1801349

1836817

35468

454715

129585752

80600209

5993247

86593455

30959884

20%

183899499

3201239

7320604

10521842

167009

167009

194254332

139245951

10269615

149515566

44486539

OFFIC

E E

QU

IPM

EN

TS

15%

19218640

75018

347881

422899

160518

160518

19481021

15709043

539706

16248749

FU

RN

ITU

RE &

FIX

TU

RES

15%

106707692

2318096

1890504

4208599

210103

49986

20960

260089

110656202

70511209

5879961

76391170

35986380

ELECTRIC

AL

INST

ALLAT

ION

S10%

306232499

1414073

63969007

65383080

1125289

1146249

370469330

177955538

16052928

194008466

127151672

10%

359605

-23166

23166

336439

264443

7200

271643

20%

73765294

2835591

-2343761

5179352

6829159

--

-

- - -

7283874

71660772

46225526

4852673

51078199

20710610

MESS

/ C

AN

TEEN

EQ

UIP

MEN

TS

30%

1176141

-17880

17880

1158261

1140008

5476

1145484

20%

32906033

872269

3535178

1158

1158

2662909

-

36440053

24098791

2201961

26300752

TO

TAL

- 31ST

MARCH

, 2018

3540569664

79638414

398883719

478522134

19459544

9705391

29164935

3989926862

3989926862

3610454710

1853541101

1947822946

1681847732

94281845

Rs.

Rs.

4474775

11017798

1354585

732060

26091

141788

3198450

-

234376

-

266291

21446214

21446214

7961800

Depr

ecia

tion

FOR

THE

YEAR

201

9-20

1ST

HAL

F

Depr

ecia

tion

FOR

THE

YEAR

201

9-20

2ND

HAL

F

Rs.

35872825

8697327

4638662

9537555

513615

5738173

1854478

7200

4618297

5476

1935670

162695278

162695278

165787371

184141492

2037682594

1667569019

94281845

96257096

56812599

153069695

4937255

242414285

-247351540

-

TO

TAL

INCLU

DIN

G C

APIT

AL

WO

RK IN

PRO

GRESS

31ST

MARCH

, 2020

PREVIO

US

YEAR IN

CLU

DIN

G

CAPIT

AL

WO

RK IN

PRO

GRESS

3634851509

3358299629

175895510

111536425

455696319

165015455

631591829

276551880

24396799

24002474

394325

252119676

-

276516475

24396799

Schedule

- IV

DEPRECIA

TIO

N

as

at

31.0

3.2

0

Delet

ionFO

R TH

E YE

AR 20

19-2

0

Tota

l 2

019-2

0

3349079

8807241

NET B

LO

CK

31.0

3.1

9as

at

CAPIT

AL

WO

RK-I

N-P

RO

GRESS

184141492

173749171

2037682594

1853541101 -

-

1761850864

1659442480

94281845

ED

P E

QU

IPM

EN

TS

LIB

RARY B

OO

KS

DESC

RIP

TIO

N

Rs.

Rs.

LAN

D

286295755

342662

30306445

BU

ILD

ING

856099890

447053497

42992299

44738765

3232267

34265032

176460866

71996

64793

VEH

ICLE

20582569

18253

12780

SOFTW

ARE

10139313

1952244270 -

as

at

31.0

3.2

0

1952244270

1756913609

40


Rs. Rs. Rs. Rs.

SCHEDULE V

Investments

SRTT Corpus 55000000 55000000

Add: Plough back Interest 10834003 65834003 10052186 65052186

MRF Corpus 45000000 45000000

Add: Plough back Interest 9546664 54546664 8926957 53926957

Corpus Fund-PS Foundation 5000000 5000000

SN Mahema Devadoss Endowment Fund 6750000 5060000

Other Corpus Investments 278492742 276097282

Total Investments 410623409 405136425

SCHEDULE VI

CURRENT ASSETS

Cash & Bank Balances

Cash in Hand 1836162 3429831

Bank Balances

- in Savings Account 25789045 55242719

- in Fixed Deposits 945907637 973532844 779031673 837704224

Loans & Advances 49120296 68090080

Deposits 16526351 14769243

Inventories 34402987 23562558

Sundry Debtors 63594952 79069324

TDS Receivable 69819054 77746634

Interest Receivable 15343885 5380637

Prepaid Expenses 15296627 21156401

Total Current Assets 1237636996 1127479101

stSCHEDULES TO BALANCE SHEET AS AT 31 MARCH 2020


PARTICULARS 31.03.2020 31.03.2019

Rs. Rs.SCHEDULE - VII

SALARIES, WAGES & EMPLOYEE BENEFITSSalaries & Wages 650209472 613361970Contribution to Provident Fund 26966444 28816857Staff Welfare Expenses 108060631 87005263Contribution to Superannuation Fund 14566683 13154358Professional Fees 153133784 142021683

952937014 884360131SCHEDULE - VIII

HOSPITAL EXPENSESDrugs & Consumables 634514162 655392600Power, Fuel & Water 82457938 82005753Repairs & Maintenance 183128002 169656577Insurance 3912248 3968525Lab Expenses 33469025 32264747Rent, Rates & Taxes 70513580 71996091

1007994955 1015284293

SCHEDULE - IX

ADMINISTRATION EXPENSESInformation Techonology Expenses 22691769 21011157Academic Expenses 59111706 52226180Communication Expenses 6409301 6899294Printing & Stationery 11154515 14816328Vehicle Expenses 12446823 14122994Security Services 31354778 26287431Camp Expenses 15992610 14862869Travelling and Conveyance 4455339 5487289Books & Periodicals 2960501 3718143Publicity Expenses 5457294 7286596Conference 28766801 41865781Subscription/Membership 3159377 1801289Function Expenses 1445922 5484060Legal & Audit Fees 2083319 2321227Bank Charges 10710936 10476910Management Consultancy Expenses 1261372 3105541Miscellaneous ExpensesLoss on Sale of Assets

21034353772318

2788479-

225338116 234561569

SCHEDULES TO INCOME AND EXPENDITURE ACCOUNT

41

SCHEDULE - XI

INTEREST

Orbis Project Expenses

Research Expenses

406765

14215232

2941

6680394

14621997 6683335

SCHEDULE - X

INTERESTInterest on ICICI Term Loan 5292444 2228357

5292444 2228357


42

stSUB SCHEDULES TO BALANCE SHEET AS AT 31 MARCH 2019

AT 31.03.1 AS AT 31.03.2020 AS 9PARTICULARS

Rs. Rs. Rs. Rs.

1. CASH AND BANK BALANCES

Cash in hand 1836162 3429831

Bank Balances

Andhra Bank 661148 643405

Indian Overseas Bank - College Road 966 45855

State Bank of India - PBB 4267406 10761987

State Bank Of India - Nungambakkam 671336 2645847

State Bank Of Mauritius -Cathedral Road 394443 1000326

HDFC Bank - Mount Road 133149 128580

HDFC Bank - Nungambakkam 168418 16767121

HDFC Bank - Corpus-Nungambakkam 2209531 2842216

HDFC Bank - Kolkata 1054861 2156399

HDFC Bank - CA-Nungambakkam 598417 2110119

ICICI Bank - Nungambakkam 6375142 871615

Development Credit Bank Ltd - Nungambakkam 1318972 3622583

HDFC Bank - SRTT MRF-Nungambakkam 36515 33093

State Bank Of India - Tada (Sricity) 121016 2095353

IOB-Mahema Devadoss Endowment Fund 11926 953130

City Union Bank - Purasawalkam 214087 2402530

IDBI Bank Ltd - Greams Road 46429 44813

State Bank of India - Mukundapur 51112 2790556

HDFC Bank - Nungambakkam - NRTT

HDFC Bank - Nungambakkam - HTPF Project

Standard Chartered Bank - Parrys

446667

4147349

2860155

25789045 81739

97320

3148132

55242719

Fixed DepositsFixed Deposits

940063738 773187774

Fixed Deposit - Voltas 5843899 5843899945907637 779031673

973532844 8377042242. LOANS & ADVANCES

Employees' - Loan 9317292 10373987

Advance for Purchases/Contracts 18576535 27623282

Rent Advance 21163869 30055811

Others 62600 49120296 37000 68090080

3. DEPOSITS

T.N.E.B 13523647 12852834

Telephone 267753 270114

Others 2734951 16526351 1646296 14769243


43

NOTES FORMING PART OF ACCOUNTS FOR THE FINANCIAL YEAR ENDED 31.03.2020

I. ACCOUNTING POLICIES

1. The Foundation follows mercantile system of accounting and recognizes Income and Expenditure on

accrual basis.

2. Financial Statements are prepared under historical cost convention.

3. The Fixed Assets of the Foundation are valued at cost less depreciation.

4. Inventories have been valued at Cost.

5. The Foundation’s contribution to various schemes of retirement benefits such as Provident Fund

and Superannuation Fund are charged to the Income and Expenditure Account every year.

6. The expenditure on unavailed leave of employees allowed to be encashed by them as per rules of

the foundation.

7. Gratuity and Leave Encashment provision have been created on the basis of actuarial valuation.

8. Donation and Grants received towards Capital Purchases are accounted under Capital Fund.

9. Donations received for Community Services accounted under Income Statement.

10. There is an Income tax demand of Rs.9.08 crores for the Assessment year 2015-16 and Rs.16.10

crores for the Assessment year 2016-17 which is pending with the Honorable High Court, Chennai

and the provision has not made as on date in the Financial Account.

l The Hon’ble High court Order No.105731 dated 18.12.2019 disposed of the writ petitions filed for

the Assessment Year 2015-16 (W.P.No.1293 & 1312 of 2018) with a direction to pass de novo order

within six weeks from 07.01.2020.

l As per Income Tax Department, ACIT (Exemptions) Letter No ITBA/COM/F/17/2019-

20/1024352760(1) dated 28.01.2020, the above order would be passed after the receipt of the

valuation report u/s. 142A and after affording reasonable opportunities to the assesse as the

valuation report sought in respect of Asst. year 2017-18 has a bearing on the de novo assessment

order to be passed for Asst. year 2015-16.


44

II.

III.

IV.

V.

11. There is also a tax demand from the Central excise department for the period from August 2012 to

June 2017 for Rs.2.43 crores which is pending with the Commissioner of Appeal I – GST & Central

Excise and a Demand and Penalty of Rs.15.69 crores for VAT from the Financial year 2011-12 to

Financial Year 2016-17 which is pending with the Honorable High Court, Chennai and the provision

has not made as on date in the Financial Accounts.

Schedules I to VI of the Balance Sheet and Schedules VII to XI of the Income and Expenditure Account

form an integral part of the Balance Sheet.

Previous year figures have been regrouped wherever necessary to conform to current year’s

classification.

Impact on COVID-19 – The Hospital was not in operation from 26th March 2020 due to COVID-19

Pandemic. This has marginally affected the functions of the foundation during the Financial Year 2019-

20.

Statutory Audit fees Rs.1,77,000/- inclusive of GST










45

HONOURS & AWARDS


l Dr Mona Khurana received the 2019 Outstanding Senior Teaching Assistant in 2019 Principles and

Practice of Clinical Research (PPCR) Program from Harvard T H Chan School of Public Health,

Boston.

l Dr Mamta Agarwal and Dr. Rajiv Raman honoured the Fellowship by the Royal College of Surgeons

(Edinburgh).

l Dr Pramod Bhende was awarded the “Medical Excellence Award for Ophthalmology” by the

World Tamil Chamber of Commerce (WTCC) on the 11th May 2019 at a function held at ‘Le Royal

Meridian’ Chennai. He received award from the former Chief Justice and Governor of Kerala,

Honourable Shri P.Sathasivam.

l The Sri SN Shah Award for equity, was conferred on Sankara Nethralaya in recognition of the

significant contribution to preventing and treating childhood blindness by the Elite School of

Optometry. Dr Anuradha Narayanan received the award from His Excellency Banwarilal Purohit,

the Honorable Governor of Tamil Nadu, at the 15th Vision 2020 Conference held on the 8th June

2019, at Arvind Eye Hospital, Chennai.

l Dr. Pramod Bhende delivered Dr. B C Sharma Memorial Oration in Vitreoretinal Sciences on

“Pediatric Retinal Detachments” at the 6th Retinal Live 2019 - 6th Retinal Congress and VR

Surgical Meet of Jaipur Ophthalmological Society on 16th to 17th June 2019 at Jaipur.

l Dr Ekta Rishi and Dr Pukhraj Rishi received the ‘Rhett Buckler Award’ for the Video presentation

titled ‘Salvaging an eye with endophthalmatis and permanent Keratoprosthesis’ at the 37th

Annual Meeting of the American Society of Retina Specialists (ASRS) held at Chicago, Illinois,

from 26th to 30th July 2019.

l Larsen & Toubro Technology Services presented an award to Medical Research Foundation in

appreciation of continuous engagement and valuable contributions towards fighting rural

blindness through Mobile Eye Care and Cataract Surgery at the Annual CSR Partners Meet held at

Bangalore on August 01st & 2nd 2019.

l “Newsweek”, the international weekly magazine, declared Sankara Nethralaya as one among

the ‘Best 4 Ophthalmological Institutions in the World for Year 2020’, based on a survey

conducted on a global basis between September and November 2019, by Statista, a leading

Research and Analysis organization and Geo Blue a trusted provider of health insurance,

especially to international tourists.

l Dr Nisar Sonam Poonam, Dr Shebin Salim, Dr Bipasha Mukherjee, and Dr Swatee Halbe received

the Best Video Award for the presentation titled “Tackling the Nidus (Embolization and Excision

of Orbital AVM)” at the 30th Annual Conference Oculoplastic Association of India (OPAI), held at

Guwahati from 6th to 8th September 2019.

46

l Dr Varsha Backiavathy was the runner up for the presentation on ”Battling a Unique Mold

(Orbito-rhino-cerebral aspergillosis)” at the Young Ophthalmologist Oculoplastic Case

Competition held at the YOSI session of the 30th Annual conference Oculoplastic Association of

India (OPAI).

l Dr Bipasha Mukherjee received the Best eposter award in lacrimal session for the poster

presentation on “Lacrimal sac Solitary Fibrous Tumor” at the 30th Annual conference

Oculoplastic Association of India (OPAI), held at Guwahati from 6th to 8th September 2019.

l Dr Nisar Sonam Poonam received the “Best Team: Avengers” in the Oculoplasty Premier League

(OPL) for the presentation on “Avenging a Volume Deficient Socket (Autologous Fat Transplant)”

at the 30th Annual conference Oculoplastic Association of India (OPAI), held at Guwahati from

6th to 8th September 2019.

l Dr Rajiv Raman was conferred with a Doctorate in Health Services by Anglia Ruskin University,

Cambridge, UK, , at its Annual Graduation Ceremony held on 14th October 2019.

l Dr Rajiv Raman received the P. Siva Reddy International Award at the 78th Annual Conference of

All India Ophthalmological Society, AIOC 2020 held in Gurugram, Haryana between 13th and 16th

February 2020.

l Dr Pukhraj Rishi received Col. Rangachari Award and Best Paper Award for his paper presentation

on “Proteomics based approach for differential diagnosis of Age Related Macular Degeneration

Subtypes” at the 78th Annual Conference of All India Ophthalmological Society, AIOC 2020 held

in Gurugram, Haryana between 13th and 16th February 2020.

l Dr Jyotirmay Biswas received the Best Poster Podium Presentation Award for his presentation on

“Polymerase Chain Reaction for M. Tuberculosis Positive Intermediate Uveitis – Analysis of 13

Cases” at the 78th Annual Conference of All India Ophthalmological Society, AIOC 2020 held in

Gurugram, Haryana between 13th and 16th February 2020.

l The Senior Citizens Group of Besant Nagar, Chennai, honoured Dr. S S Badrinath with the Most

Admired Gandhian of Tamil Nadu Award on 1st November 2019.

l Dr. Ronnie George was honoured the Dr Noel Moniz Oration Award in the 46th Annual Conference

of Kerala Society of Ophthalmic Surgeons held from 22nd to 24th Nov 2019 at Lulu international

Conventional Centre, Thrissur.

l Sankara Nethralaya was chosen as the ‘Best Healthcare Institution’ at the D2d (Dare to Dream

Awards- Season-2) organized jointly by Zee Business and SAP, India. Dr Girish Shiva Rao,

President & Medical Director, MRF received the ‘Zee Dare to Dream’ Award-2019 from Dr

Rajendra Kumar, Principal Secretary & Industries Commissioner, Government of Tamil Nadu; Mr

Ritwik Ray, Senior Sales Manager, SAP, India and Mr Lal Singh, General Manager, Union Bank Of

India, Chennai at the award ceremony held at the Hyatt Regency, Chennai on 1st December

2019.


47

l Dr. Ekta Rishi received the Best Video Award for the presentation of “Salvaging an eye with

Endophthalmitis and Permanent Keratoprosthesis at the 28th Annual Conference of Vitreo

Retinal Socieity – India, held at Lucknow from 5th to 8th December 2019.

l Dr P P Santanam was honoured with the “Dr. C K Ramchander Life Time Achievement Award” by

Indian Association of Occupational Health (IAOH), at the 70th National Conference of Indian

Association of Occupational Health held at Nehru Center, Mumbai on 29th January 2020.

l Dr. T. S. Surendran was conferred with the “Lifetime Achievement Award” by the International

Association of Lions Club Dt. 324 A1, Region IV on 1st February 2020.

l Dr.Rizwana Husaindeen has been appointed as the ‘President of the American Academy of

Optometry (AAO) India Chapter on 24th February 2020.

l Dr V V Jaichandran attended the 5th World Congress of Ophthalmic Anesthesia (WCOA), held at

Jakarta, Indonesia on 7th and 8th February 2020. His E-Poster titled ‘Mannequin Based Training

of Regional Ophthalmic Anaesthesia’ received the 1st Runner-up Prize Award.

l Dr V V Jaichandran elected as the International President for World Congress of Ophthalmic

Anaesthesia, WCOA, for the years 2020-2024.

l Sankara Nethralaya celebrated 80th Birthday of its beloved Chief Dr. S S. Badrinath on 24th

February 2020. On this special occasion, 100 cost free cataract surgeries were performed on

indigent patients as a befitting tribute and birthday gift to its Founder and Chairman Emeritus Dr

S S Badrinath.

l Dr. Ronnie George has been elected as the Section Editor of Indian Journal of Ophthalmology;

Member of the Editorial Board in the Journal of Glaucoma, and Journal of Tamil Nadu

Ophthalmic Association.

l Dr. Rajiv Raman has been elected as a Member, AIOS National Taskforce for Diabetic Retinopathy

– 2019, Member of Speciality Board of National Board of Examination, Government of India 2019.

l Dr. Rajiv Raman appointed as the Grant Reviewer for Swiss National Science Foundation and

Diabetes UK.

l Dr. S Meenakshi has been elected as a member of the Editorial Board of Indian Journal of

Ophthalmology for Paediatric Ophthalmology and Centre for Ophthalmic Educators of the

International Council of Ophthalmology.

l Dr Mamta Agarwal has been elected as the Reviewing Editor of the Journal of Ocular Immunology

and Inflammation.

l Dr Dhanashree Ratra has been selected as the Section Editor for Surgical Retina in the Indian

Journal of Ophthalmology.

l Dr Dhanashree Ratra received an award for Best Research at the International Conference of the

Women's Ophthalmologic Society held at Bangalore in September 2019.

l Dr. Anuradha was conferred with the Fellowship of American Academy of Optometry.


48

l Rajasekaran, S., Nagarajha Selvan, L.D., Dotts, K., Kumar, R., Rishi, P., Khetan, V., Bisht, M.,

Sivaraman, K., Krishnakumar, S., Sahoo, D. and Campbell, M.J., 2019. “Non-coding and coding

transcriptional profiles are significantly altered in pediatric retinoblastoma tumors” Frontiers

in oncology, April 9, p.221

l Vinita Girish Rao�, M.K. Janani, Jyotirmay Biswas “Real-time polymerase chain reaction in

recurrent cytomegalovirus anterior uveitis”, Am J Ophthalmol Case Rep. 2019 May 20;

15:100470.

l Karthikka Palanisamy, Coral Karunakaran, Rajiv Raman, Subbulakshmi Chidambaram.

“Optimization of an in vitro bilayer model for studying the functional interplay between human

primary retinal pigment epithelial and choroidalendothelial cells isolated from donor eyes”.

BMC Res Notes, May ,2019.

l Kannadasan Anand Babu, Parveen Sen, Narayanasamy Angayarkanni. “Oxidized LDL,

homocysteine, homocysteine thiolactone and advanced glycation end products act as pro-

oxidant metabolites inducing cytokine release, macrophage infiltration and pro-angiogenic

effect in ARPE-19 cells” PlosOne, May, 2019

l Gulshan V, Rajan RP, Widner K, Wu D, Wubbels P, Rhodes T, Whitehouse K, Coram M, Corrado G,

Ramasamy K, Raman R, Peng L, Webster DR. “Performance of a Deep-Learning Algorithm vs

Manual Grading for Detecting Diabetic Retinopathy in India” JAMA Ophthalmol. 2019 Jun

13;137(9):987-93.

l Dutta Majumder P, Mistry S, Luthra S, Shrutanjoy M Das, Sekar V, Rishi E, Biswas J. “Atypical

posterior pole retinitis” Am J Ophthalmol Case Rep. 2019 Jun 13;15:100494.

l Rishi P, Multani P, Prasan VV, Rishi E, Attiku Y. “Choroidal thickness in Waardenburg syndrome”

GMS Ophthalmol Cases. 2019 Jun 18;9: Doc 22.

l Kulandhai LT, Bhagavathi H, Krishnan S, Krishnan K, Balasubramaniyam M, Madhavan HN.

“Seroprevalence of Anti-HIV-1, Anti-HIV-2, Hepatitis B Surface Antigen, and Anti-HCV in Eye

Donors in a Tertiary Eye Hospital, Chennai, India, in the Past 13 years (2005-2017)”, Cornea.

2019 Jun;38(6):737-741.

l Choudhari NS, Richhariya A, Wadke V, Deshmukh SP, George R, Senthil S, Chandra Sekhar G. “The

Outcomes of a Comprehensive Program for Maintenance of Goldmann Applanation Tonometer” J

Glaucoma. 2019 Jun;28(6):507-511.

l Meethal NS, Pel JJ, Mazumdar D, Asokan R, Panday M, van der Steen J, George R. “Eye Movement

Perimetry and Frequency Doubling Perimetry: clinical performance and patient preference

during glaucoma screening” Graefe's Archive for Clinical and Experimental Ophthalmology. 2019

Jun 4;257(6):1277-87.

RESEARCH PUBLICATIONS

INTERNATIONAL JOURNALS :


49

l Sudhir RR, Dey A, Bhattacharrya S, Bahulayan A. “AcrySof IQ PanOptix Intraocular Lens Versus

Extended Depth of Focus Intraocular Lens and Trifocal Intraocular Lens: A Clinical Overview”

Asia Pac J Ophthalmol (Phila). 2019 Jul-Aug;8(4):335-349.

l Srinivasan S, Raman R, Kulothungan V, Pal SS, Roy R, Ganesan S, Sharma T. “Four-year Incident

Neuropathy and its Risk Factors in Subjects with Type 2 Diabetes” J Assoc Physicians India. 2019

Jul;67(7):34-37.

l Wadke V, Lingam V, George R, George AE, Ganesh SK, Biswas J, Balekudaru S.

“Phacotrabeculectomy in Eyes with Uveitic Glaucoma: A Retrospective Case-Control Study” J

Glaucoma. 2019 Jul;28(7):606-612.

l Ruamviboonsuk P, Krause J, Chotcomwongse P, Sayres R, Raman R, Widner K, Campana BJL,

Phene S, Hemarat K, Tadarati M, Silpa-Archa S, Limwattanayingyong J, Rao C, Kuruvilla O, Jung

J, Tan J, Orprayoon S, Kangwanwongpaisan C, Sukumalpaiboon R, Luengchaichawang C,

Fuangkaew J, Kongsap P, Chualinpha L, Saree S, Kawinpanitan S, Mitvongsa K, Lawanasakol S,

Thepchatri C, Wongpichedchai L, Corrado GS, Peng L, Webster DR. “Erratum: Author Correction:

Deep learning versus human graders for classifying diabetic retinopathy severity in a nationwide

screening program” NPJ Digit Med. 2019 Jul 23;2:68.

l Deepmala Mazumder, Najiya S Kadavath Meethal Manish Pandey, Rashima Asokan. “Effect of

Age, Sex Stimulus Intensity, and Eccentricity on Saccadic Reaction Time in Eye Movement

Perimetry”. Transl Vis Sci Technol. 2019 Jul; 8(4): 13.

l Rupak Roy, Kumar Saurabh, Dhaivat Shah, Maitreyi Chowdhury, Sugandha Goel. “Choroidal

Hyperreflective Foci: A Novel Spectral Domain Optical Coherence Tomography Biomarker in Eyes

with Diabetic Macular Edema” Asia Pac J Ophthalmol (Phila) Jul-Aug 2019;8(4):314-318.

l Singh N, Jain M, Jaisankar D, Sharma T, Raman R Sankara Nethralaya Vitreoretinal Study Group

(SNVR-Study Group). “Bilateral Simultaneous Rhegmatogenous Retinal Detachment: Clinical

Characteristics and Surgical Outcome” Retina. 2019 Aug; 39(8):1504-1509.

l John S, Srinivasan S, Raman R, Ram K, Sivaprakasam M. “Validation of a Customized Algorithm

for the Detection of Diabetic Retinopathy from Single-Field Fundus Photographs in a Tertiary Eye

Care Hospital” Stud Health Technol Inform. 2019 Aug 21;264:1504-1505.

l Nikhalashree S, George R, Shantha B, Lingam V, Vidya W, Panday M, Sulochana KN, Coral K.

“Detection of Proteins Associated with Extracellular Matrix Regulation in the Aqueous Humour of

Patients with Primary Glaucoma” Curr Eye Res. 2019 Sep;44(9):1018-1025.

l Aberami S, Nikhalashree S, Bharathselvi M, Biswas J, Sulochana KN, Coral K. “Elemental

concentrations in Choroid-RPE and retina of human eyes with age-related macular

degeneration”. Exp Eye Res, Sep 2019.

l Ganesh SK, Abraham S, Sudharshan S. “Paradoxical reactions in ocular tuberculosis” J

Ophthalmic Inflamm Infect. 2019 Sep 6;9(1):19.

l Saurabh K, Roy R, Thomas NR. ”Multicolor Imaging Characteristics of Best's Vitelliform Macular

Dystrophy” Middle East Afr J Ophthalmol. 2019 Sep 30;26(3):178-180.


50

l Wong W, Sundar G, Chee C, Zhao PS, Rajagopalan R, Gopal L. “Clinical spectrum, treatment and

outcomes of uveal melanoma in a tertiary centre” Singapore Med J. 2019 Sep;60(9): 474-

478.

l Alam MS, Jain M, Mukherjee B, Sharma T, Halbe S, Jaisankar D, Raman R. ”Visual impairment in

high flow and low flow carotid cavernous fistula” Sci Rep. 2019 Sep 6;9(1):12872.

l Rishi P, Majumder PD, Biswas J. “Anterior Chamber Migration of Fluocinolone Acetonide

Intravitreal Implant” JAMA Ophthalmol. 2019 Sep 1;137(9):e185931.

l Rishi P, Sharma U, Sharma T. “Cavitary retinoblastoma: clinical observations” Eye (Lond).

34(4):704-710. Epub 2019 Sep 18.

l Kuppan K, Mohanlal J, Mohammad AM, Babu KA, Sen P, Undurti ND, Natarajan V, Narayanasamy

Angayarkanni. “Elevated Serum OxLDL is associated with progression of type 2 Diabetes Mellitus

to Diabetic Retinopathy” Exp Eye Res. Sep 2019.

l Gopakumar V, Agarwal S, Srinivasan B, Krishnakumar S, Krishnan UM, Iyer G. ”Clinical Outcome

of Autologous Cultivated Oral Mucosal Epithelial Transplantation in Ocular Surface

Reconstruction” Cornea 2019 Oct;38(10):1273-1279.

l Sen P, Wu WC, Chandra P, Vinekar A, Manchegowda PT, Bhende P. “Retinopathy of prematurity

treatment: Asian perspectives” Eye (Lond) 2020 34(4):632-642. Epub 2019 Oct 29.

l Dutta Majumder P, Shah A, Madhuravasal Krishnan J, Rishi E. “Driving in Fog without Headlight:

Management of a Challenging Case of Presumed Ocular Toxoplasmosis” Curi ALL. Ocul Immunol

Inflamm. 2019 Oct 2:1-3.

l Reddy AVC, Mani R, Selvakumar A, Hussaindeen JR “Reading eye movements in traumatic brain

injury” J. Optom. 2019 Nov 26:S1888-4296(19)30102-5.

l Agrawal R, Mahajan S, Agarwal A, Gunasekeran DV, Raje D, Aggarwal K, Murthy SI, Westcott M,

Chee SP, McCluskey P, Ho SL, Teoh S, Cimino L, Biswas J, Narain S, Agarwal M, Mahendradas P,

Khairallah M, Jones N, Tugal-Tutkun I, Babu K, Basu S, CarreÃ±o E, Lee R, Al-Dhibi H, Bodaghi B,

Invernizzi A, Goldstein DA, Herbort CP, Barisani-Asenbauer T, GonzÃ¡lez-LÃ³pez JJ, Androudi S,

Bansal R, Moharana B, Esposti SD, Tasiopoulou A, Nadarajah S, Agarwal M, Abraham S, Vala R,

Singh R, Sharma A, Sharma K, Zierhut M, Rousselot A, Grant R, Kon OM, Cunningham ET, Kempen

J, Nguyen QD, Pavesio C, Gupta V. “Tubercular Uveitis: Nuggets from Collaborative Ocular

Tuberculosis Study (COTS)-1Testi I” Ocul Immunol Inflamm. 2019 Nov 25:1-9.

l Barh A, Mukherjee B, Koka K, Krishnakumar S. “Triton tumor of the orbit”, Orbit. 2019 Nov 20:1-

4.

l Shah A, Rajesh PS, Dutta Majumder P. “Iris cyst following cataract surgery” Clin Exp Optom. 2019

Nov 14.

l Singh S, Neriyanuri S, Raman R. “Management of macular edema with branch retinal vein

occlusion in a case of secondary polycythemia” GMS Ophthalmol Cases. 2019 Nov 20;9:Doc38.


51

l Sampath NikhalaShree, Gayathree Karthikkeyan, Ronnie George, BalekudaruShantha, Lingam

Vijaya, Vineet Ratra, Konerirajapuram Natarajan Sulochana, Karunakaran Coral. “Lowered

Decorin With Aberrant Extracellular Matrix Remodeling in Aqueous Humor and Tenon's Tissue

From Primary Glaucoma Patients” Invest Ophthalmol Vis Sci, Nov, 2019.

l Sen P, Abraham S, Jain S, Gopal L, Bhende P. “Treatment outcomes of zone 1 retinopathy of

prematurity: A study from a tertiary eye care center in South India” Taiwan J Ophthalmol. 2019

Dec 13;9(4):255-261.

l Choudhari NS, George R, Asokan R, Khanna R, Vijaya L, Garudadri CS. “Combination of Simple

Diagnostic Tests to Detect Primary Angle Closure Disease in a Resource-constrained Region”

Ophthalmic Epidemiol. 2019 Dec;26(6):430-438.

l Agrawal R, Agarwal A, Jabs DA, Kee A, Testi I, Mahajan S, McCluskey PJ, Gupta A, Palestine A,

Denniston A, Banker A, Invernizzi A, Fonollosa A, Sharma A, Kumar A, Curi A, Okada A, Schlaen A,

Heiligenhaus A, Kumar A, Gurbaxani A, Bodaghi B, Islam Shah B, Lowder C, Tappeiner C, Muccioli

C, Vasconcelos-Santos DV, Goldstein D, Behra D, Das D, Makhoul D, Baglivo E, Denisova E,

Miserocchi E, Carreno E, Asyari F, Pichi F, Sen HN, Uy H, Nascimento H, Tugal-Tutkun I, Arevalo JF,

Davis J, Thorne J, Hisae Yamamoto J, Smith J, Garweg JG, Biswas J, Babu K, Aggarwal K, Cimino

L, Kuffova L, Agarwal M, Zierhut M, Agarwal M, De Smet M, Tognon MS, Errera MH, Munk M,

Westcott M, Soheilian M, Accorinti M, Khairallah M, Nguyen M, Kon OM, Mahendradas P, Yang P,

Neri P, Ozdal P, Amer R, Lee R, Distia Nora R, Chhabra R, Belfort R, Mehta S, Shoughy S, Luthra S,

Mohamed SO, Chee SP, Basu S, Teoh S, Ganesh S, Barisani-Asenbauer T, Guex-Crosier Y, Ozyazgan

Y, Akova Y, Habot-Wilner Z, Kempen J, Nguyen QD, Pavesio C, Gupta V; , “Standardization of

Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study

(COTS) Workshop Collaborative Ocular Tuberculosis Study (COTS) Group.” Ocul Immunol

Inflamm. 2019 Dec 10:1-11.

l Goel S, Saurabh K, Roy R. “Multicolour imaging in retinochoroidal coloboma” , Clin Exp Optom.

2019 Dec 5.

l Anuradha Narayanan, Mohan Venkadesan, Sruthisree Krishnamurthy, Jameel R Hussaindeen,

Krishna Kumar Ramani. “Dalton’s pseudo-isochromatic plates and congenital colour vision

deficiency.” Clin Exp Optometry: 2019; Dec; 1-5

l Singh P, Madhuravasal Krishnan J, Kumar A, Roy R, Biswas J. ”Cladosporium Endogenous

Endophthalmitis Mimicking Toxoplasma Retinochoroiditis” Ocul Immunol Inflamm. 2019 Dec

11:1-2.

l Khurana M, Alam MS, Balekudaru S, Vijaya L, Madhuri MB, Halbe SV, Noronha VO, George RJ,

Mukherjee BJ, “Intraocular Pressure in the Eyes of Patients With Carotid-Cavernous Fistulas:

Profile, Intereye Asymmetry, and Treatment Outcomes Glaucoma” Journal of Glaucoma 2019

Dec;28(12):1074-1078.

l Rishi P, Trivedi M, Sreelakshmi K. “Choroidal Nevus and Melanoma in Patients with

Oculocutaneous Albinism” Ocul Oncol Pathol. 2020 Jan;6(1):31-34.


52

l Najiya Sundus, Velumuri Lokapavani, Rashima Asokan, Lingam Vijaya, Ronnie George. “SITA

Standard testing with Humphrey Visual field analyser versus full threshold testing with

frequency doubling perimetry: a comparison of patient preference and perception”. Asian

Journal of Ophthalmology, January 2020.

l Naik AU, Raman R. “Bilateral Choroidal Osteomas with Choroidal Neovascularization” JAMA

Ophthalmol. 2020 Jan 1;138(1):e190059.

l Sen P, Singh N, Rishi E, Bhende P, Rao C, Rishi P, Bhende M, Sharma T, Gopal L. “Outcomes of

surgery in eyes with familial exudative vitreoretinopathyassociated retinal detachment”

Can J Ophthalmol. E-pub 2020 Jan 13:S0008-4182(19)30953-6.

l Jaisankar D, Kumar M, Rishi P, Singh S, Raman R. “Correlation of retinal changes with choroidal

changes in acute and recurrent central serous chorioretinopathy assessed by swept-source

optical coherence tomography” Ther Adv Ophthalmol. 2020 Jan 20;12:2515841419899823.

l Verma A, Alagorie AR, Ramasamy K, van Hemert J, Yadav NK, Pappuru RR, Tufail A, Nittala MG,

Sadda SR, Raman R Indian Retina Research Associates (IRRA). “Distribution of peripheral lesions

identified by mydriatic ultra-wide field fundus imaging in diabetic retinopathy” Graefes Arch

Clin Exp Ophthalmol. Epub 2020 Jan 27.258(4):725-733.

l Shah A, Biswas J. “Cytopathology and Polymerase Chain Reaction of Vitreous Fluid in Tubercular

Intermediate Uveitis”, Ocul Immunol Inflamm. 2020 Jan 6:1-3.

l Varuna Kumaran, Krishna Kumar, Naveen Mahesh, B.E. “Application of an Online Homework Tool

in Optometry for Geometric Optics Improves Exam Performance”. Optometric Education: 2020.

l Ayisha Atiya, Jameel Rizwana Hussaindeen, Supraja Kasturirangan, Srikanth Ramasubramanian,

K Swathi Meenakshi Swaminathan. “Frequensy of undetected binocular vision anomalies among

ophthalmology trainees”. Journal of Optometry: Jan 2020; 1-8.

l Mazumdar D, Lal B, Asokan R. “Anterior segment optical coherence tomography of intrastromal

corneal cysts”. Asian Journal of Ophthalmology. Jan 2020;17(1):41-4.

l Dalan D, Jaisankar D, Mani K, Madhu A, Ratra D. “A multifocal electroretinography study to

evaluate risk of developing macular hole in the fellow eye of patients suffering with unilateral

macular hole” Ther Adv Ophthalmol. 2020 Feb 26;12:2515841420908697.

l Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, Ademola-Popoola DS, Adio A,

Afshar AR, Aggarwal P, Aghaji AE, Ahmad A, Akib MNR, Al Harby L, Al Ani MH, Alakbarova A,

Portabella SA, Al-Badri SAF, Alcasabas APA, Al-Dahmash SA, Alejos A, Alemany-Rubio E, Alfa Bio

AI, Alfonso Carreras Y, Al-Haddad C, Al-Hussaini HHY, Ali AM, Alia DB, Al-Jadiry MF, Al-Jumaly U,

Alkatan HM, All-Eriksson C, Al-Mafrachi AARM, Almeida AA, Alsawidi KM, Al-Shaheen AASM, Al-

Shammary EH, Amiruddin PO, Antonino R, Astbury NJ, Atalay HT, Atchaneeyasakul LO, Atsiaya R,

Attaseth T, Aung TH, Ayala S, Baizakova B, Balaguer J, Balayeva R, Balwierz W, Barranco H,

Bascaran C, Beck Popovic M, Benavides R, Benmiloud S, Bennani Guebessi N, Berete RC, Berry

JL, Bhaduri A, Bhat S, Biddulph SJ, Biewald EM, Bobrova N, Boehme M, Boldt HC, Bonanomi

MTBC, Bornfeld N, Bouda GC, Bouguila H, Boumedane A, Brennan RC, Brichard BG, Buaboonnam

J, CalderÃ³n-Sotelo P, Calle Jara DA, Camuglia JE, Cano MR, Capra M, Cassoux N, Castela G,


53

Castillo L, CatalÃ -Mora J, Chantada GL, Chaudhry S, Chaugule SS, Chauhan A, Chawla B,

Chernodrinska VS, Chiwanga FS, Chuluunbat T, Cieslik K, Cockcroft RL, Comsa C, Correa ZM,

Correa Llano MG, Corson TW, Cowan-Lyn KE, CsÃ³ka M, Cui X, Da Gama IV, et a , “Global

Retinoblastoma Presentation and Analysis by National Income Level” Global Retinoblastoma

Study Group, Fabian ID JAMA Oncol. 2020 Feb 27;6(5):1-12.

l Zakir SM, Alam MS, Askari SN, Imran M. “Pattern of ocular morbidity among students in a school

for visually impaired children in North India” Oman J Ophthalmol. 2020 Feb 17;13(1):24-28.

l Ravishankar H, Mangani AS, Shankar MB, Joshi M, Devasena T, Parameswaran S, Subramaniam K

“Characterization of NCC-RbC-51, an RB cell line isolated from a metastatic site” Histochem

Cell Biol. 2020 Feb;153(2):101-109.

l Sen P, Attiku Y, Bhende P, Rishi E, Ratra D, Sreelakshmi K. “Outcome of sutured scleral fixated

intraocular lens in Marfan syndrome in pediatric eyes” Int Ophthalmol. 2020 Feb 28.

l Lakra R, Shah A, Kaushik V, Biswas J, Dutta Majumder P. “Use of Anti-Tumour Necrosis Factor-

Alpha Agents in the Management of HLA-B-27-Associated Uveitis: The First Case Series from

India” Ocul Immunol Inflamm. 2020 Feb 14:1-5.

l Agarkar S, Koladiya N, Kumar M, Vijaya L, Raman R. “Nanophthalmos in children: morphometric

and clinical characterization” J AAPOS. 2020 Feb;24(1):27.e1-27.e5.

l Khurana M, Shah DD, George RJ, Vijaya L, Balekudaru S. “Phacoemulsification in eyes with

long anterior zonules” J Cataract Refract Surg 2020 Feb;46(2):209-214.

l Agarwal S, Majumder PD. “Pseudomonas aeruginosa scleritis initially presenting as idiopathic

diffuse anterior scleritis” Oman J Ophthalmol. 2020 Feb 17;13(1):51-52.

l Radosavljevic A, Agarwal M, Bodaghi B, Smith JR, Zierhut M. “Medical Therapy of Uveitic Macular

Edema: Biologic Agents” Ocul Immunol Inflamm. 2020 Feb 14:1-12.

l Sen P, Sudharshan S, Banerjee A, Dhami A. “Clinical and electrophysiological characteristics of

Efavirenz-induced macular toxicity” GMS Ophthalmol Cases. 2020 Feb 27;10:Doc08.

l Philip R, Balekudaru S, Vijaya L, George R. “Intraocular Pressure Outcomes after Surgery for

Rhegmatogenous Retinal Detachment in Schwartz Syndrome” Retina. 2020 Feb 7.

l Dhami A, Shah KK, Anshuman K, Ratra D. “Correspondence“ Retina. 2020 Mar; 40(3):e11.

l Gopalakrishnan S, Jacob CES, Kumar M, Karunakaran V, Raman R. Hyungtaek Rim T, Ryo K, Tham

YC, Kang SW, Ruamviboonsuk P, Bikbov MM, Miyake M, Hao J, Fletcher A, Sasaki M, Nangia V,

Sabanayagam C, Yu M, Fujiwara K, Thapa R, Wong IY, Kayama T, Chen SJ, Kuang TM, Yamashita H,

Sundaresan P, Chan JC, van Rens GHMB, Sonoda KH, Wang YX, Panda-Jonas S, Harada S, Kim R,

Ganesan S, Raman R, Yamashiro K, Gilmanshin TR, Jenchitr W, Park KH, Gemmy Cheung CM,

Wong TY, Wang N, Jonas JB, Chakravarthy U, Cheng CY, Yanagi Y, Saenmee A, Cao K, George R,

Kazakbaeva GM, Khalimov TA, Khanna RC, Kim HW, Kulothungan V, Nangia P, Mao F, Matsuda F,

Meng Q, Namba H, Pokawattana N, Oh J, Park SJ, Ravindran R, Sharma T, Shin JP, Surya J,

Takahashi A, Takebayashi T, Tsujikawa A, Vashist P, Wei WB, Yang X, Yu SY, Zainullin RM, Zhao PQ.

“Comparison of Visual Parameters between Normal Individuals and People with Low Vision in a

Virtual Environment” Cyberpsychol Behav Soc Netw. 2020 Mar;23(3):171-178.


54

l Alagappan LP, Koh JEW, V J, Ramesh A, Bhende M, Raman R, Acharya UR, Mathavan S.

“Development of an automated system for the detection of genotype in polypoidal choroidal

vasculopathy using retinal image phenotype” Comput Methods Programs Biomed. Epub 2020

Mar 19.

l Kumar M, van Dijk EHC, Raman R, Mehta P, Boon CJF, Goud A, Bharani S, Chhablani J. “Stress and

vision-related quality of life in acute and chronic central serous chorioretinopathy” BMC

Ophthalmol. 2020 Mar 6;20(1):90.

l Asia Ruamviboonsuk P, Cheung CY, Zhang X, Raman R, Park SJ, Ting DSW. “Artificial Intelligence

in Ophthalmology: Evolutions” Asia Pac J Ophthalmol (Phila). 2020 Mar-Apr;9(2):78-84..

l Alam MS, Vijay V, Barh A, Subramanian K. “Plasma cell granuloma of the conjunctiva in a young

female” Orbit. 2020 Mar 1:1-4.

l Rahman Z, Jafarullah O, Huq N, Hasan K, Magesan K, Dutta Majumder P. “Clinical Profile of

Patients with Scleritis in Bangladesh” Ocul Immunol Inflamm. 2020 Mar 4:1-4.

l Gupta P, Pradeep S, Biswas J, Rishi P, Muthusamy R. ”Extensive Chorio-retinal Damage Due to

Dirofilaria Repens- Report of a Case” Ocul Immunol Inflamm. 2020 Mar 11:1-3.

l Iyer G, Srinivasan B, Agarwal S, Subramanian K. “Ectopic sebaceous glands of Gibsan in eyelid

margin- A novel manifestation in Stevens Johnson Syndrome & proposed nomenclature based on

an observational case series” Ocul Surf. Epub 2020 Mar 16: S1542-0124(20) 30056-2.

NATIONAL JOURNALS :

l Gopalakrishnan Sarika, Dinesh Venugopal, M V S Sailaja, Sheela Evangeline, Ramani K Kumar.

Barriers and enablers to low vision care services in a tertiary eye care hospital: A Mixed Method

Study. Indian J Ophthalmol. 2019 April; Vol 67, Issue 4 , 536-540

l Rishi P, Singh N, Rishi E.“Retinopathy in incontinentia pigmenti” Indian J Ophthalmol. 2019 May;

67(6):940-942.

l Aditya Maitray, Ekta Rishi, Pukhraj Rishi, Lingam Gopal, Pramod Bhende, Rupak Ray, Kuzhanthai

Lily Therese. “Endogenous endophthalmitis in children and adolescents: Case series and

literature review” Indian J Ophthalmol. 2019 Jun;67(6):795-800.

l Naik AU, Rishi E, Rishi P. “Pediatric vitreous hemorrhage: A narrative review” Indian J

Ophthalmol. 2019 Jun;67(6):732-739.

l Sharma N, Arora T, Singhal D, Maharana PK, Garg P, Nagpal R, Murthy S, Gunnam S, Arora A,

Prajna V, Rajaraman R, Padmanabhan P, Kumar A, Kumar R, Tomar S, Thomas A, Gyanchand R,

Arora R, Biswas B, Basak S. “Procurement, storage and utilization trends of eye banks in India”

Indian J phthalmol. 2019 Jun;67(7):1056-1059.

l Shah KK, Rishi E, Bhende P, Rishi P, Sharma T. “To remove the buckle or watch?” Indian J

Ophthalmol. 2019 Jun;67(6):973-974.


55

l Sen P, Agarwal A, Bhende P, Gopal L. “Surgical outcomes of vitreoretinal surgery for

rhegmatogenous retinal detachment in eyes with regressed retinopathy of prematurity” Indian

J Ophthalmol. 2019 Jun;67(6):896-902.

l Rishi E, Srinivasan B, Singh N, Gopal L. “Late onset Descemet's membrane detachment: 15 years

after limbal lensectomy with vitrectomy for ROP” Indian J Ophthalmol. 2019 Jun;67(6):965-966.

l Sen P, Bhende P, Sharma T, Gopal L, Maitray A, Shah P, Oke Y. “Surgical outcomes of microincision

vitrectomy surgery in eyes with retinal detachment secondary to retinopathy of prematurity in

Indian population” Indian J Ophthalmol. 2019 Jun;67(6):889-895.

l Goel S, Das D, Saurabh K, Roy R. “Multicolour imaging in retinal astrocytoma” Indian J

Ophthalmol. 2019 Jul;67(7):1167-1168.

l Das D, Boddepalli A, Biswas J.”Clinicopathological and immunohistochemistry correlation in a

case of Vogt-Koyanagi-Harada disease” Indian J Ophthalmol. 2019 Jul;67(7):1217-1219.

l Lakshmipathy M, Susvar P, Popet K, Rajagopal R. “Subconjunctival bevacizumab and argon laser

photocoagulation for preexisting neovascularization following deep lamellar anterior

keratoplasty” Indian J Ophthalmol. 2019 Jul;67(7):1193-1194.

l Ratra D, Yadav H, Dalan D, Sodhi PKS, Ratra V. ”Retinal vascular abnormalities in Sturge-Weber

syndrome” Indian J Ophthalmol. 2019 Jul;67(7):1223-1226.

l Anshuman K, Ramesh V, Dalan D, Ratra D. “Ophthalmic artery occlusion following blunt trauma”

Indian J Ophthalmol. 2019 Jul;67(7):1183

l Alam MS, Tongbram A, Krishnakumar S, Mukherjee B. “Ciliochoroidal melanoma presenting as

bleeding anterior staphyloma: Report of a case and review of literature” Indian J Ophthalmol.

2019 Jul;67(7):1162-1163.

l Anshuman K, Ratra D. “Commentary: Ziv-aflibercept: An alternative antivascular endothelial

growth factor agent for polypoidal choroidal vasculopathy” Indian J Ophthalmol. 2019

Jul;67(7):1119-1120.

l Majumder AK, Sheth S, Dharani V, Dutta Majumder P. “An unusual case of tuberculous optic

neuropathy associated with choroiditis” Indian J Ophthalmol. 2019 Jul;67(7):1210-1212.

l Agarwal AM, Dutta Majumder P. “Tubercular posterior scleritis: A case report and review of

literature” Indian J Ophthalmol. 2019 Aug;67(8):1362-1365.

l Dutta Majumder P; Jayshree, David RL, Kaushik V. “A case of idiopathic necrotizing scleritis with

secondary glaucoma treated successfully with golimumab and Ahmed valve implantation”

Indian J Ophthalmol. 2019 Aug;67(8):1360-1362.

l Biswas J “Commentary: Seeing a worm in the eye - Is it enough?” Indian J Ophthalmol. 2019

Sep;67(9):1492-1493.


56

l Dutta Majumder P, Mayilvakanam L, Palker AH, Sridharan S, Biswas J. ”Intravitreal sustained-

release dexamethasone implant for the treatment of persistent cystoid macular edema in

ocular syphilis“ Indian J Ophthalmol. 2019 Sep;67(9):1487-1490.

l Subramaniam Rajesh Bharathi Devi, Karunakaran Coral, Karthikeyan Gayathree, Muthuvel

Bharathselvi, Shanmuganathan Sivasankar, Jyotirmoy Biswas, Pukhraj Rishi, Sundaram

Natarajan, Sengamedu Srinivasa Badrinath, Narayanasamy Angayarkanni. “Case report on two

diabetic donor eyes with no retinopathy: Clinicopathological and molecular studies” Indian

Journal of Ophthalmology, September 2019.

l Roy R, Saurabh K, Shah D, Goel S. “Treatment outcomes of pachychoroid neovasculopathy with

photodynamic therapy and anti-vascular endothelial growth factor” Indian J Ophthalmol. 2019

Oct;67(10):1678-1683.

l Schouten IM, Palkar AH, Bhende M. “Macular vortex vein with choroidal neovascularisation in

pathologic myopia” Indian J Ophthalmol. 2019 Oct;67(10):1717-1718.

l Latiff N, Sudharshan S, Verma A, Khetan V, Biswas J. “Iridocilary tuberculoma mimicking

melanoma” Indian J Ophthalmol. 2019 Nov;67(12):2048-2049.

l Mukherjee B, Moosa S, Rajagopal R. “Cavernous hemangioma of the conjunctiva“ Indian J

Ophthalmol. 2019 Nov;67(12):2061.

l Gudkar AI, Mukherjee B, Krishnakumar S. “Solitary Fibrous Tumor of the lacrimal sac“ Indian J

Ophthalmol. 2019 Nov; 67(12):2043-2044.

l Biswas J. “Commentary: As is our pathology, so is our practice” Indian J Ophthalmol. 2019 Dec;

67(12):1996.

l Attiku Y, Khetan V.”Commentary: Prognostication of uveal melanoma based on molecular

diagnosis - Are we there yet?” Indian J Ophthalmol. 2019 Nov; 67(12):1964.

l Alam MS, Tongbram A, Krishnakumar S, Biswas J, Mukherjee B. “Sensitivity and specificity of

frozen section diagnosis in orbital and adnexal malignancies” Indian J Ophthalmol. 2019

Dec;67(12):1988-1992.

l Das D, Krishnakumar S, Biswas J. “Sympathetic ophthalmia with incidental finding of chicken

pox supported by histopathology and immunohistochemistry” Indian J Pathol Microbiol. 2019

Oct-Dec;62(4):592-594.

l Shah A, Rao C, Kumar K, George RJ, Dutta Majumder P. “Inflammatory deposits on the foldable

intraocular lens” Indian J Ophthalmol. 2020 Jan;68(1):190-191.

l Badrinath SS, Narayanan A, Hussaindeen JR, Surendran TS. “The Sankara Nethralaya Community

model - Technology and evidence based comprehensive quality eye care equally to all” Indian J

Ophthalmol. 2020 Feb;68(2):288-290.

l Rijey J, Goel S, Saurabh K, Roy R. ”A rare case of ruptured optic disc retinal arterial

macroaneurysm and its successful management with intravitreal ranibizumab” Indian J

Ophthalmol. 2020 Jan;68(1):200-201.


57

l Dutta Majumder P, Menia N, Sudharshan S, Rao C, Ganesh SK, Biswas J. “Response to comments

on: Clinical profile of uveitis patients developing central serous chorioretinopathy - An

experience at a tertiary eye care center in India” Indian J Ophthalmol. 2020 Jan;68(1):269-270.

l Bhende PS. “Retinopathy of prematurity” Indian J Ophthalmol. 2020 Feb; 68 (Suppl 1):S10-S11.

l Dutta Majumder P. “Commentary: Tick talk: A glimpse into the literature“ Indian J Ophthalmol.

2020 Jan;68(1):104-105.

l Madanagopalan VG, Raman R. “Commentary: Artificial intelligence and smartphone fundus

photography - Are we at the cusp of revolutionary changes in retinal disease detection?” Indian

J Ophthalmol. 2020 Feb;68(2):396-397.

l Jain S, Raman R. “Autofluorescence in scleral buckle intrusion” Indian J Ophthalmol. 2020

Mar;68(3):527.

l Kunal K Shah and Pramod S Bhende. “Swiss-cheese macula” Indian J Ophthalmol. 2020 Mar;

68(3): 526.

l Dalan D, Nandini P, Angayarkanni N, Kaviarasan K, Thanikachalam S, Das UN, Ratra D.

“Interchangeability of retinal perfusion indices in different-sized angiocubes: An optical

coherence tomography angiography study in diabetic retinopathy” Indian J Ophthalmol. 2020

Mar;68(3):484-489.

l Bassi ST. “Commentary: Viewing Alzheimer's disease from an ophthalmologist's eyes” Indian J

Ophthalmol. Epub 2020 Mar 16;68(4):562-563.

l Dutta Majumder P, Koka K, Noronha V. “An unusual case of orbital myositis in a patient with HLA

B-27-associated uveitis” Indian J Ophthalmol. Epub Mar 2020.

l Das D, Biswas J, Bhattacharjee H. “Commentary: Pattern of uveitis in a tertiary eye care center

of central India: Results of a prospective patient database over a period of two years” Indian J

Ophthalmol. 2020 Mar;68(3):482-483.


58

l Protocol No. ILD432-P001 An Observational, Prospective, Post-Marketing Clinical Study of the

ACRYSOF® IQ PanQptix Multifocal IOL in an Indian Population. [Dr Prema Padmanabhan]

l Knowledge and Attitude about Colour Vision Deficiency among stakeholders of school eye

screening- A qualitative study [Dr Anuradha N]

l Profile of Binocular Vision function in patients with Keratoconus [Dr Prema Padmanabhan]

l Measurement of Aqueous Flare: Comparison between Kowa FM 700 Laser Flare Meter and Spot

fluorometer [Principal Investigator : Dr. Prema Padmanabhan]

l Persistent Low grade inflammation following Corneal Transplantation – a possible cause for

enhanced endothelial attrition [Principal Investigator : Dr. Prema Padmanabhan]

l Neurotrophins and inflammatory markers in the progression of pre-diabetes to Type II Diabetes

Mellitus and Diabetic Retinopathy [Dr Dhanashree Ratra]

l Visual Rehabilitation using video game stimulation and teleophthalmology- a pilot study [Dr

Dhanashree Ratra]

l A system for measurement of amblyopia and strabismus – specific quality of life using item

banking and computer adaptive testing (Eye-tem bank) [Dr Jameel Rizwana H]

l Exploring maturation of visual perception in school age children using portable devices [Dr

Anuradha N/Dr Jameel Rizwana H]

l Binocular vision parameters pre and post LASER vision surgery (LASIK and Epi-LASIK) [Ms.

Sushmitha A D]

l Changes on Ocular surface due to Anti - Glaucoma medications [Dr Rashima A]

l Structural and functional analysis in different severities of glaucoma using Spectral Domain

Optical Coherence Tomography and Humphrey Visual Field Analyzer [Mr. Manideepak Januwada]

l Influence of astigmatism and pupil size on near visual performance such as reading speed and

contrast acuity in pseudophakic eyes [Dr Rashima A]

l Impact of dichoptic training on motor fusion in amblyopia [Dr Jameel Rizwana Hussaindeen]

l Development of virtual reality prototype using dichoptic viewing for amblyopic training [Dr

Jameel Rizwana Hussaindeen]

l Vision Related Quality of Life (VRQOL) in mild and moderate traumatic brain injury (TBI) – pre

and post Neuro-Optometric Vision therapy [Dr Jameel Rizwana Hussaindeen]

l Neuro-optometric rehabilitation in Homonymous Hemianopia using Yoked prisms and Sanet

vision integrator [Dr Jameel Rizwana Hussaindeen]

l A knowledge, attitude and practice (KAP) survey of binocular vision care among eye care

practitioners in India [Dr Jameel Rizwana Hussaindeen]

COMPLETED PROJECTS:


59


l Dopamine and Melatonin in tear and serum among myopes [Ms. Azfira Hussain / Ms. Aparna G]

l The combined influence of neuropathy and retinopathy in people with diabetes [Dr Rajiv Raman]

l To understand the barriers and facilitators of Diabetic Retinopathy Screening & follow up: An

exploratory study from India and Thailand [Dr Rajiv Raman]

l Study of the real time performance of Artificial intelligence-based algorithm on images taken

with a fundus camera for detecting and grading diabetic retinopathy and glaucoma [Principal

Investigator : Dr. Rajiv Raman]

l Role of single bolus does Dexedetomidine in providing smooth extubation and prevention of

emergence delirium in paediatric ocular surgeries: A single blind randomized trial [Principal

Investigator: Dr.Sonali Raman]

l Comparison of Intraocular lens power calculations obtained from Argos biometer and Ultrasound

biometry in paediatric cataracts [Principal Investigator : Dr. Sumita Agarkar]

l Efficacy of topical Timolol for ocular pyogenic granuloma [Principal Investigator : Dr. Sonam

Nisar]

l Critical incidents and morbidity in paediatric patients undergoing ophthalmic surgery under

general anaesthesia in a tertiary care single specialty hospital [Dr. S Lakshmi Prasanna]

l Does B-scan and fundus auto fluorescence help discriminate pseudo disc edema from true disc

edema [Dr. S Ambika]

l Development and Validation of a Deep Learning Algorithm for Detection of Optic Disc

Abnormalities [Dr. S Ambika]

DNB THESIS PROJECTS :

l Anatomical and Functional Outcomes of Surgery For Retinal Detachment in Closed globe injury

due to Cricket Ball. [Principal Investigator : Dr. Sankadasariya Daxa Bhupatbhai] Guide: Dr. Muna

Bhende

l Visual outcome following intravitreal anti vegf for macular edema in different morphological

pattern, based on spectral domain optical coherence tomography. [Principal Investigator : Dr.

Ayush Singh] Guide: Dr. P.S. Rajesh

l Structural changes [GCL+IPL and RNFL] in optical coherence tomography in relation to clinical

profile and visual outcomes of optic neuritis patients in Indian population. [Principal

Investigator : Dr.Mitesh Jatan Bafna] Guide: Dr. S. Ambika

l Clinical spectrum of HLA-B27 associated ocular inflammation. [Principal Investigator : Dr.

Ruchika Raini Lakra] Guide: Dr. Parthopratim Dutta Majumder

l Comparison of risk factors, clinical features, visual outcome of central serous chorioretinopathy

in women presenting to a tertiary eye care centre in the past 10 years. [Principal Investigator :

Dr. Syed Moosa SM] Guide: Dr. Vikas Khetan

60

l REACH- Refractive error among children [Dr T.S. Surendran]

l Sankara Nethralaya Tubercular Uveitis (SANTU) Study [Dr. J Biswas]

l Construction and validation of a pediatric perimeter based on eye tracking technology [Dr

Ronnie George]

l Normative data collection for oculomotor functions using prototype eye-tracking technology in

accordance with the conventional method [Dr Ronnie George]

l Protocol Number: ILJ466-P005: Post-Market Clinical Study of the Clareon® AutonoMe TM with

Indian Population [Principal Investigator : Dr. Prema Padmanabhan]

l Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (MERIT) – A Phase 3 Study

Dr. Sudha Ganesh]

l The Asia Primary Tube versus Trabeculectomy (TVT) Study [Dr Ronnie George]

l To study the characteristics of optic nerve head by OCT angiography after IOP reduction: A

prospective study [Dr. Ronnie George / Dr. B Shantha / Dr. L Vijaya]

l Clinical Imaging Study – Glaucoma [Dr Ronnie George / Dr L Vijaya / Dr B Shantha]

l The Indian Childhood Glaucoma Incidence Study [Dr B Shantha]

l Electrophysiological studies in eyes receiving Intravitreal Chemotherapy for Retinoblastoma [Dr

Pukhraj Rishi]

l Comparison of outcomes of different gas tamponade agents for macular hole surgery [Dr Pukhraj

Rishi]

l CRISEPTED Combined radiotherapy and intravenous steroids for the treatment of Early

Progressive Thyroid Eye Disease [Dr Bipasha Mukherjee]

l Early improvement in visual functions after anti-vegf in Center involving Diabetic Macular

Edema [Dr Rajiv Raman]

l Improving the Compliance of Patients with Diabetic Retinopathy for Regular Screening and

Follow-up after Treatment of Sight Threatening Diabetic Retinopathy [Dr Rajiv Raman]

l Aniso-accommodation In Children With Anisometropic Amblyopia [Dr Meenakshi S]

l A Comparative study of Reading speed of anisometropic amblyopia with age matched visually

normal children at a tertiary eye care center [Dr Meenakshi S]

l Efficacy study of two cycloplegic regimens in eyes with dark irides [Dr Meenakshi S]

l A Pilot study on Comparative analysis of MIC (Minimum Inhibitory Concentration) and MPC

(Mutant Prevention Concentration) of normal human commensal conjunctival microbial flora to

topical antibiotics. [Dr Meena Lakshmipathy]

ONGOING PROJECTS


61

l Vision related Quality of Life in patients with low vision using the IVI -VLV questionnaire [Dr.

Mona Khurana/Dr. Anuradha N]

l Evaluating the effectiveness of a Dot Pattern Visual Cognition Task for the assessment of visual

sequencing and visualization aptitude in elementary school children [Dr Jameel Rizwana H]

l Diagnostic accuracy of indigenously developed computer based binocular vision testing and

efficacy of computer based vision therapy [Dr Jameel Rizwana H]

l Development and validation of a prototype to assess visual reaction time among visually normal

individuals and patients with traumatic brain injury [Dr Jameel Rizwana Hussaindeen]

l Pattern of Anomalous retinal correspondence (ARC) and efficacy of in-office vision therapy in

improving fusional vergence amplitudes in Intermittent Divergent Squint (IDS) [Dr Jameel

Rizwana Hussaindeen]

l Sankara Nethralaya - Tamil Nadu Essilor Myopia (STEM) Study [Ms. G Aparna/Dr S

Viswanathan/Dr Jameel Rizwana]

l Evaluating the association of soft contact lens wear among contact lens wearers in their daily

activities, life style, occupation, and socio economic status [Ms. Sutapa Purkait]

l SNEHAM 2020 – Sankara Nethralaya Eye Hospital Anjali to Mahatma [Dr. Anuradha N]

l Clinical profile and Surgical outcomes of patients with Familial exudative vitreoretinopathy

(FEVR) [Principal Investigator : Dr. Ekta Rishi]

l A prospective study to analyze the meibographic features in chalazion and sebaceous gland

carcinoma [Dr. Sonam Nisar]

l Prevalence of self-reported Falls among Visually impaired visiting Tertiary eye hospital

[Principal Investigator : Ms S Ramya]

l A Prospective comparative study of the Functional visual outcomes of three different Intra

Ocular Lenses Bifocals, Trifocals and Extended depth of focus lenses [Principal Investigator : Dr

Shikha Rajesh Bassi]

l Blur threshold and blur adaptability assessment in young adult myopic patients undergoing

refractive surgery [Principal Investigator : Dr R R Sudhir]

l Evaluation of Macular Pigment Optical Density in Diabetic Retinopathy and correlation with its

severity in Non center involving macular edema [Principal Investigator : Dr Rajiv Raman]

l Protocol Title: 19140 Structured Post-marketing surveillance to collect the safety data of

intravitreal aflibercept injection (IVT-AFL) in patients of wet age-related macular degeneration

during real world clinical practice [Principal Investigator : Dr. Parveen Sen]

l Role of Multimodal Imaging In Presumptive Tubercular Posterior Uveitis – A Prospective Study

[Principal Investigator : Dr. Jyotirmay Biswas]


62

l Study of nested and real-time polymerase chain reaction for mycobacterium tuberculosis DNA in

the aqueous fluid of granulomatous intermediate uveitis a prospective study [Principal

Investigator : Dr. Jyotirmay Biswas]

l Respiratory viral Infections in Children with Febrile Neutropenia in Haemato-Oncology

Unit.[Principal Investigator : Dr. H N Madhavan / Dr. Adarsh Kancharla]

l BYNOCS DAT (Dichoptic Amblyopia Therapy) Game treatment for Amblyopia – A randomized

controlled trial. [Principal Investigator: Dr. Jameel Rizwana Hussaindeen]

l Impact of Scleral contact lens in pediatric age group. [Principal Investigator: Ms. Sona Paul]

l Vault-Aberration-Vision relationship in Boston Scleral contact lens. [Principal Investigator: Ms

Akshaya Balakrishnan]

l Protocol Study Code: ET1901001, Evaluation of efficacy and safety of bimatoprost 0.01%

(Careprost LS) preservative-free [PF] ophthalmic solution in comparison to conventional

bimatoprost 0.01% (Lumigan) Ophthalmic solution for glaucoma or ocular hypertension in Indian

population. [Principal Investigator: Dr. Parivadhani A]

l Analysis of Retinal and Choroidal Structure using Swept Source Optical Coherence Tomography

Angiography in healthy Indian eyes [Principal Investigator: Dr. Aditya Verma]

l Protocol No.:010906IN, Title: Lumina: A Phase III, Multicenter, Sham-Controlled, Randomized,

Double-Masked Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 uq DE-

103 for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye

[Principal Investigator : Dr. J Biswas]

l Protocol ID/Number: CRTH258B2302 A Two-Year, Two-Arm, Randomized, Double-Masked,

Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab versus Aflibercept

in Adult Patients with Visual Impairment due to Diabetic Macular Edema [Dr.Muna Bhende]

l Impact of Occupational Optometry Services on Productivity and Vision Related Quality of Life of

Small scale and Cottage Industry workers [Dr. Rashima A]

PH.D RESEARCH PROJECT :

l Low vision intervention in individuals with retinal diseases [Ms. Sarika G; Guide: Dr Rajiv Raman]

DNB THESIS PROJECTS :

l Clinical Profile and Short Term Outcome of Patients Sustaining Ophthalmic Injury due to Festive

Bursting of Firecracker managed in the emergency department at a Tertiary Eye Care Center

[Principal Investigator : Dr.Amulya Das; Guide: Dr. Pradeep Susvar]

l A Retrospective Analysis of Topography of Optic Nerve Head Drusens on Spectral Domain OCT

[Principal Investigator : Dr.Ramesh Pamu; Guide: Dr. Shikha Rajesh Bassi]

l Natural history of keratoconus in patients of age more than 40 years. [Principal Investigator : Dr

Shridhar Kulkarni; Guide: Dr. Meena Lakshmipathy]


63

l Cataract Surgery in Fuchs Endothelial Corneal Dystrophy [Principal Investigator :Dr. Suhasini J;

Guide: Dr. Sudhir.R. R]

l Characteristics features of Macular Telangiectasia Type 2 using OCT-Angiography. [Principal

Investigator : Dr Damisetti Anjali] Guide: Dr. Parveen Sen

l Study of Corneal Biomechanics in corneal Dystrophies Using Corvis St [Principal Investigator :

Dr.Shruthi.P.S] Guide: Dr.Niveditha Narayanan

l Inflammatory Neuroretinitis: Etiology and Treatment outcome in a tertiary care uveitis center.

[Principal Investigator : Dr. Pallavi Goel] Guide: Dr.Suchitra Pradeep

l Comparison of intra ocular pressure reduction in primary open angle glaucoma, ocular

hypertension, primary angle closure and primary angle closure glaucoma with topical anti

glaucoma medications. [Principal Investigator : Dr Arun S] Guide: Dr Ronnie George

l Stargardt disease – Correlation between genotype and phenotype in Indian population.[Principal

Investigator – Dr Mythri K Rao] Guide : Dr Muna Bhende

l A retroprospective study of Phacoemulsification with Toric intraocular lens with and without

image guided marking to study the impact of image guided technology. [Principal Investigator –

Dr Ashok Kumar Mandal] Guide : Dr Shikha Rajesh Bassi

l Visual outcome in children with congenital rubella cataract versus non rubella cataract.

[Principal Investigator : Dr. Visakh Thomas] Guide: Dr. Sumita Agarkar / Co-Guide: Dr. Mona

Khurana

l An observational case series on outcomes of corneal collagen cross linking in Non- Keratoconus

corneal ectasia. [Principal Investigator : Dr. Sagar Udasi] Guide: Dr. Radhika Natarajan

l Comparison of the visual outcome and short term complications following cataract surgery with

vitreous loss between eyes with Anterior chamber intraocular lens and Posterior chamber

intraocular lens. [Principal Investigator : Dr. Merin Jacob] Guide: Dr. Sripriya Krishnamoorthy

l Utility of High Frequency Biomicroscopy in the Diagnosis and Treatment of Uveitis [Principal

Investigator : Dr Lavanya S; Guide: Dr. Suchitra Pradeep]

l Quantification of Vascular changes in Retinal Vein Occlusion using Optical Coherence

Tomography Angiography (OCTA) and to find the Correlation between Vascular Indices and

Cardiovascular Risk Factors [Principal Investigator : Dr Preethi B; Guide: Dr. Dhanashree Ratra]

l Management Outcomes of Ophthalmic Manifestations of Carotid-cavernous fistulas in Indian

Population [Principal Investigator : Dr Amol Yuvraj Ganvir; Guide: Dr. Bipasha Mukherjee / Co-

Guide: Dr.Swatee V. Halbe (Apollo Speciality Hospital, Chennai)]

l Outcomes of Surgical Management of Descemet’s Membrane Detachment during Cataract

Surgery in a Training Centre [Principal Investigator : Dr Aman Agrawal; Guide: Dr. Sripriya

Krishnamoorthy]


64

l Comparative study of Surgical Outcome in Phacoemulsification with Posterior Polar Cataract in 2

ERAS 10 years apart in a group of surgeons [Principal Investigator : Dr. Adheela Abdulla; Guide:

Dr. Shikha Bassi]

l Clinical Profile, Diagnosis and Management of Familial Exudative Vitreoretinopathy in the Indian

Population [Principal Investigator : Dr Thatigotla Naga Amulya; Guide: Dr. Girish S Rao]

l Correlation of Digital Slit Lamp Photography with Clinical features in Infective Keratitis.

[Principal Investigator : Dr Doshi Aashna Premal; Guide: Dr. N Radhika]

l Treatment Outcomes Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections

in Patients with Myopic Choroidal Neovascularization [Principal Investigator : Dr Ganesh V;

Guide: Dr Vikas Khetan]

l Analysis of Retinal Changes with Optical Coherence Tomography Angiography in Patients having

Diabetic Macular Edema with Proliferative Diabetic Retinopathy as Compared with those having

Diabetic Macular Edema without Proliferative Diabetic Retinopathy before and after Anti-

Vascular Endothelial Growth Factor Therapy [Principal Investigator : Dr Nila D Dev; Guide: Dr.

Aditya Verma]

l Exploring, Developing and validating a predictive model for OCT markers of Inflammation vs

Angiogenesis in Macular Edema [Principal Investigator : Dr Meenakshi Mahesh; Guide: Dr. Rajiv

Raman]

l Impact of Optic Disc size on Retinal Nerve Fiber Thickness in Normal Eyes and Glaucomatous Eyes

[Principal Investigator : Dr Sitesh Vats; Guide: Dr. Ronnie Jacob George]

l Study of risk factors for corneal decompensation following Cataract Surgery in Patients of Fuchs

Endothelial Corneal Dystrophy [Principal Investigator : Dr Saurabh Gupta; Guide: Dr. R R Sudhir]

l A Clinical and Microbiological Study of Panophthalmitis Cases managed in a Tertiary Care Centre

[Principal Investigator : Dr Mehta Parth Kirit; Guide: Dr. Chetan Rao]

l Hospital Anxiety and Depression Scale Assessment of patients with intraocular tumor before and

after therapy [Principal Investigator : Dr Khandharwar Mahavir; Guide: Dr. Pukhraj Rishi]

l A Study of swept source OCT and OCT -Angiography features of Pathological Myopia [Principal

Investigator : Dr Amber Dubey; Guide: Dr. Pradeep S]

l Functional Outcome of Descemet Membrane Endothelial Keratoplasty in Corneal Endothelial

Disorders [Principal Investigator : Dr Sneha Bhopatkar; Guide: Dr. Bhaskar Srinivasan]

l Comparison of Accuracy of 8 Intra Ocular Lens Power Calculation Formulas in patients

Undergoing Cataract Surgery [Principal Investigator : Dr. Catharine Joby; Guide: Dr.Vineet

Ratra]

l Visual Outcome Post Cataract Surgery in Patients with an Axial Length more than 26mm

[Principal Investigator : Dr. Radhika Sriram; Guide: Dr. P S Rajesh]

l Visual Outcomes and Morbidity in Pediatric Uveitis Patients in Tertiary Care Centre [Principal

Investigator : Dr Sivakoti Rama Naga Prasanna; Guide: Dr. Parthopratim Dutta Majumder]


65

l Outcomes of therapeutic penetrating keratoplasty in fungal keratitis [Principal Investigator : Dr.

Marella Alekya; Guide: Dr. Mamta Agarwal]

RA FELLOWSHIP :

l Cellular and molecular study on the prevalence of viral induced pathogenesis of pterygia in India

and evaluation of the role of adjuvants in anti fibrogenic activity Dr. M K Janani [Guide: Dr. H. N.

Mathavan]

Ph.D :

l A prospective study to analyze the impact regarding awareness about exercise measures and

adoption of better postures pertaining to musculo-skeletal disorders (MSD) among post-

graduates in the ophthalmology stream. Dr. Vishnu Vahan Prasan [Guide: Dr. R R Sudhir]

M.OPTOMETRY PROJECT :

l The effect of therapeutic intervention on the ocular lipid layer in Stevens Johnson Syndrome [Mr

Soumen Sadhu Guide: Dr Bhaskar Srinivasan/ Dr Geetha Iyer]

l Nagel Anamoloscope, Its normative database, test retest variability and utility in optic nerve

head pathologies. [Ms. Nabanita Ghosh Guide: Dr. Rashima A]

l Establishment of clinical profile of pseudoexfoliation in a hospital based setup and comparison

of the structural changes between pseudoexfoliation and pseudoexfoliation glaucoma [Mr

Sourabh Jandyal [Guide: Dr. Rashima A]

l Visual functions following successful anatomical reattachment in macula off Retinal

detachment [Ms. Jebacynthia [Guide: Dr Muna Bhende/Dr. Jameel Rizwana Hussaindeen]

l Assessment of Accommodative parameters and pupillary responses in Duane’s Retraction

Syndrome (DRS) [Mr. Bongoni Viswanath [Guide: Dr. Jameel Rizwana Hussaindeen]

l Analysis of change in visual function in individuals with Low vision using Samsung Gear – Pilot

Study Ms. Gnanapoonkodi B [Supervisor: Dr Rajiv Raman]


66


l Dr. Prema Padmanabhan and Dr .Vikas Khetan, participated in the ARVO Conference from 25th

April 2019 to 04th May 2019. They made a Poster Presentations on “Spectrum of Binocular Vision

Function in Keratoconus Patients” and “Aqueous flare in uveitis: Measurements with an

enhanced spot fluorometer”.

l Dr. Prema Padmanabhan participated in the CME in Narayana Nethralaya at Bangalore from 18th

to 19th May 2019.

l Dr. Vijaya L attended the CME at Ludhiana from 27th to 29th April 2019.

l Dr. Pramod S Bhende participated in the Sankara Nethralaya Kolkata CME on 20th to 21st April

2019.

l Dr. Jaichandran V V attended the Vision 2020 Annual Conference at Aravind Eye Hospital on 08th

June 2019. He gave a presentation on “Minimizing and Managing Systemic Emergencies

occurring in an Eye Hospital”.

l Dr. Jaichandran V V participated in the 67th Annual conference of Indian Society of

Anaesthesiologists (IAS) at Bangalore from 26th to 29th 2019.

l Dr. Pramod S Bhende participated in the RETNET conference at Bangalore from 08th to 09th June

2019.

l Dr. Pramod S Bhende participated in the ROP conference at Hyderabad from 12th to 14th June

2019.

l Dr. Pramod S Bhende, Dr. Parveen Sen and Dr. Pukhraj Rishi, attended the 4th Annual conference

of Indian Retinopathy of Prematurity Society at Hotel J W Marriott & Auditorium, Advanced Eye

Centre, PGIMER, Chandigarh from 21st to 22nd June 2019. Dr. Pramod S Bhende presented on

“Management of stage 4 ROP”, Dr.Parveen Sen on “Is it ROP or FEVR ?”, “Early surgery for

APROP” and Dr. Pukhraj Rishi on “Case presentation - Stretch retinal hole in post-vitrectomised

eye for stage IV-A ROP”.

l Dr. Pradeep S attended the Retnet conference at Bangalore from 07th to 08th June 2019.

l Dr. Rajiv Raman participated in the Retina Beyond meeting at Taiwan from 21st to 22nd June

2019.

l Dr. Sudhir R R attended Vision 2020 Annual conference at Arvind Eye Hospital on 08th June 2019.

l Dr. Jaichandran V V Participated in the State conference ISACON at Chennai, Tamilnadu from

27th to 28th July 2019. He gave a presentation on “Ophthalmic Blocks”.

l Dr. P. Durgadevi attended “Hands on workshop on microbiome screening and pathogen

identification using Nanopore sequencing technology” conducted by Genotypic technology at

Bangalore on 13th July 2019.

l Dr. L. Dhanurekha, Dr. P. Durgadevi, attended the IERG conference held on 27th and 28th July

2019 at Chennai. Dr. L. Dhanurekha has presented poster entitled “Application of Novel duplex

PCR for the rapid detection of Pythium insidiosum in corneal specimens of ocular pythiosis

patients” and Dr. P. Durgadevi on “Reverse Transcriptase PCR (RT-PCR) for detection of Toll like

Receptors in infective fungal keratitis samples”.

PARTICIPATION IN CONFERENCES

67


l Dr. Mona Khuran, Dr. K. Lily Therese, Dr. A. R. Anand & Dr. Reni Philip attended the Asia ARVO IERG

held at Ambassador Pallava from 27th to 28th July 2019.

l Dr. Muna Bhende and Dr. Parveen sen attended the Retinal Imaging Congree 2019 at Chaithanya

Eye Hospital at Thiruvananthapuram from 18th to 20th July 2019.

l Dr. Jyotirmay Biswas, Dr. Smita Praveen, Dr. Bhaskar Srinivasan, Dr. Meena Lakshmipathy, Dr

Suganeswari, Dr. Kavita Kalaivani, Dr Rajiv Raman , Dr. Meenakshi Swaminathan, Dr.

Parivadhini.A, Dr. Mona Khurana, Dr. Rathini Lilian David, Dr. Radhika N, Dr. Suchitra pradeep

Participated in the 67th Annual Conference of Tamil Nadu Ophthalmic Association at Salem from

09th to 11th August 2019. Dr. Jyotirmay Biswas presented the topic “A case of Vogt Koyanagi

Harada’s disease”, Dr. Bhaskar Srinivasan “Surgical management of Dry Eye”, Dr. Meena

Lakshmipathy “Acanthamoeba keratitis”, Dr Suganeswari “Principles and goals of surgery in

vitrectomy for rhegmatogenous RD” , “The Bodhi Tree Session B-Scan”, Dr. Kavita Kalaivani

“Cortical visual impairment- the Ophthalmologist's role in early detection and management”, Dr

Rajiv Raman “Artificial Intelligence and DR screening – where are we today?”, “Oblique muscle

surgeries”, Dr. Parivadhini.A “Tubes & Shunts”, “A focus on diode cyclophotocoagulation and

micro pulse diode”, Dr.Rathini Lilian David “Can SLT be used as a primary treatment modality?”,

“A critical review of the LiGHT trial.2”, Dr. Mona Khurana “Endoscopic cyclophotocoagulation:

When and How to perform”, Dr.Trupti Sudhir Patil “Practical and evidence based use of Lasers in

angle closure disease and plateau iris” and Dr. Radhika N presented on “Symposium Keratitis –

Assorted”.

l Dr. Muna Bhende, Dr. Parveen Sen and Dr .Pramod S Bhende participated in the Retina forum

meeting at Delhi from 24th to 25th August 2019.

l Dr. Jaichandran V V participated in the 05th OFISACON conference at Bengaluru- from 06th to

07th September 2019. He made a presentation “Regional anaesthesia for Open Globe Injury”.

l Dr. Kannan R participated in the OFISA conference at Bangalore on 07th to 8th

September 2019. He gave a presentation on “Mandatory Documentation: NABH Stranded

Perspectives”.

l Dr. Prema Padmanabhan, Dr. Rama Rajagopal, Dr. Radhika N and Dr. Sudhir R R participated in the

10th Eucornea Congress 2019 from 11th to 19th September 2019. Topics “Unusual corneal

flattening following collagen crosslinking for keratoconus: overtreatment or over-response?”,

“Fate of the untreated fellow eye of patients with bilateral keratoconus with unilateral collagen

crosslinking”, “Clinical and microbiological profile of eyes collected from multiorgan donors in a

tertiary care centre - Can they be used?”, “Visual Outcomes Of Penetrating Keratoplasty In Eyes

With Iridocorneal Endothelial Syndrome(Ice)” were presented by the team.

l Dr. Manonmani B participated in the Ophthalmic Anaesthesia Society annual conference at

Chicago from 11th to 20th September 2019. She gave a poster presentation on “Hyaluranidase

Hypersensitivity after peribulbar Block Hard to diagnose - is it?”.

l Dr Sujatha R participated in the 33rd Ophthalmic Anaesthesia Society Conference at Chicago

from 11th to 15th September2019. She gave a talk on “Anaesthesia for Neonates”.

68


l Dr. Shantha B, Dr. Sripriya Krishnamurthy, Dr. Vijaya L, Dr Ronnie Jacob George and Dr.

Parivadhini A, attended the Glaucoma society of India conference at Lucknow from 20th to 22nd

September 2019. Dr. Parivadhini A presented on topic "Angle closure Disease - Medical

management of Glaucoma".

l Dr Pramod S Bhende, Dr. Muna Bhende and Dr. Vinata Muralidharan participated in the EuRetina

conference at Paris 2019 from 05th to 8th September 2019. Dr. Promod Bhende gave a

Presentation on “Pediatric retinal detachments - No child’s play” , “A lens, an IOL and a giant

retinal tear (GRT) – The result of a fishing expedition” and Dr. Muna Bhende presented on “To

study the surgical and functional outcome of vitrectomy for retinal detachment (RD) secondary

to cytomegalovirus retinitis (CMVR) in patients with acquired immune deficiency syndrome

(AIDS)”.

l Dr.Vikas Khetan attended the OPAI meeting at Guwahati from 05th to 07th September 2019.

l Dr. Niveditha Narayanan, participated in the Women Ophthalmologists Society (WOS 2019) at

Hotel Sheraton Grand, Bengaluru, India from September 08th to 10th 2019. She made a

presentation on “Aberrations In Pellucid Marginal Degeneration (PMD)”.

l Dr Meena Lakshmipathy participated in the pediatric conference at LVPEI, Hyderabad,

Telangana from 08th to 10th November 2019. She made a presentation on “Advanced Paediatric

Cornea and Neurotisation Workship”.

l Dr. Sudha K Ganesh , Dr. Amala Elizabeth , Dr. Sudharshan S, Dr. Parthapratim Dutta Majumder

attended the USI meeting at Bangalore from 19th to 22nd September 2019.

l Dr. Parthapratim Dutta Majumder, Dr. Sharanya Sarah Abraham, attended the All Gujarat

Ophthalmological Conference Ahmedabad from 27th to 28th September 2019.

l Dr. Anuradha N participated in the American Academy of Optometry Conference at Orlando,

Florida from 21st to 31st October 2019. She gave a talk on “Role of school eye screening in

promoting gender equity".

l Dr.Rama Rajagopal, Dr. Radhika N, participated in the 32nd APACRS Annual meeting at Kyoto

from 03rd to 05th October 2019. Dr. Rama Rajagopal presented on “Deep Anterior Lamellar

keratoplasty (DALK) in corneal scars and dystrophies” and Dr. Radhika N presented a paper titled

“Outcome of Cornela perforation”, Video Presentation titled in the mind’s eye”.

l Dr. Sripriya Krishnamurthy, Dr. Muna Bhende, Dr. Pramod S Bhende and Dr. Girish S Rao attended

the MOSCON Conference at Mumbai from 18th to 19th October 2019. Dr. Sripriya Krishnamurthy

presented on “phacoemulsification basics” and “glaucoma in corneal diseases”.

l Dr. Radhika N and Dr. Niveditha Narayanan Participated in the Bug Buster at Corneal Infection

workshop 2019 at Hyderabad on 19th October 2019. Dr. Niveditha Narayanan presented the topic

“Pseudomonas Keratitis Our Roles and Responsibilities” and Dr. Radhika N presented on

“Infectious Keratitis -Protocol for Bacterial Keratitis”.

l Dr. A R Anand and Dr. P. Durgadevi, participated in the “International Science Symposium on HIV&

Infectious Diseases at Sri Ramachandra Institute of Higher education and research (SRIHER) from

12th to 14th October 2019.

69


l Dr. A. R. Anand attended SIRCON meeting on 12th October and 13th October 2019. He delivered a

talk entitled “PCR in uveitis” at the Pre-conference CME programme on 12th October 2019.

l Dr. L. Dhanurekha, Ms. Harinee R participated in the SIRCON conference held on 12th and 13th

October 2019 at Chennai. Ms. Harinee R has presented poster entitled “Curcumin alleviates LPS-

induced pro-inflammatory cytokine expression in hepatic stellate cells” and Dr. L. Dhanurekha

presented Poster entitled “Molecular detection of Mycobacterium tuberculosis genome from

suspected Ocular Tuberculosis patients- A four year retrospective study from a tertiary eye care

hospital”.

l Dr. A. R. Anand attended CME program entitled “Nephelometry & Its Clinical Applications” on

16th October 2019 at Benzzpark T.Nagar.

l Dr. Pramod S Bhende participated in the CME on Surgical Retina on 12th October 2019.

l Dr. Sudhir R R, attended 32nd APACRS Annual Meeting at Kyoto from 03th to 05th October 2019.

He made a presentation on “Long term outcomes of Keratoconus patients after Topography

guided custom ablation with collagen cross linking (TCAT + CXL)”.

l Iyer Geetha Krishnan and Dr. Bhaskar Srinivasan attended the American Academy of

Ophthalmology in SFO, from 12th to 15th October 2019. Dr. Bhaskar presented the Breakfast

Kpro Meeting Topic “K-pro in oil filled eyes”, he is the co-Instructor for the “Pediatric Corneal

Conditions- IC”, Topic “Pediatrics DALK”, he is the Wet lab Instructor in OSD Skill Transfer

Wetlab. Dr. Iyer Geetha Krishnan presented the Breakfast Kpro Meeting Topic “Carrier graft

melts and their management”, E-Poster titled “Kpro-The Journey after”, Skill Transfer Course

“KPro for the very dry patient”, IC course “Pediatric Corneal Conditions”, topic “Paediatric

OSD”, “AMT vs. Alloslet in severe grade ocular chemical injuries”, and E-Poster titled “Long term

Outcomes of MMG for SJS”.

l Dr. Girish Rao attended the 43rd Annual Conference of Madhya Pradesh Atate Ophthalmic Society

at Madhya Pradesh from 18th to 20th October 2019.

l Dr. Arshee S Ahmed participated in the CME Programme on 12th October 2019.

l Dr. Ronnie Jacob George attended the Kerala Society of Ophthalmic Surgeons:[KSOS] at Kerala

from 21st to 23rd November 2019. He gave presentations on “Clues to a Neurological component

on Perimetry in a glaucoma patient, Structure- function correlation in glaucoma, High frequency

focused Ultrasound endocyclophotocoagulation, Surface tension and thin fluids (gas and hydro

techniques), Aurolab Aqeous Drianage Implant Late Bleb associated complications and

management.”

l Dr. Meena Lakshmipathy, participated in the CME on Infectious Keratitis at Aravind Eye Hospital,

on 3rd November 2019. She made a presentation on “Debate on Bacterial Keratitis – Clinical Vs

Microbiological Post CXL Infections”.

l Dr. Niveditha Narayanan participated in the EBAI conference at Hyderabad from 09th to 10th

September 2019. She made a presentation on “Optical Grade Donor Corneas for therapeutic

penetrating Keratoplasties (PK)”.

70


l Dr. Muna Bhende attended the LVPEI Oration at Hyderabad on 16th November 2019.

l Dr. Amala Elizabeth George, Dr. Sudharshan S and Dr. Mamta Agarwal participated in the

International ocular Inflammation Society (IOIS) at Taiwan from 12th to 16th November 2019.

l Dr. Sudharshan S participated in the KOSON conference at Belagavi from 08th to11th November

2019.

l Dr. Sudhir R R attended the EMR Implementation at Chaitanya Eye Hospital from 13th to 14th

November 2019.

l Dr. Shobha Ravishankar attended the conference on First European Society of Ophthalmic

Anaesthesia held in Engelberg, Switzerland from 03rd to 08th December 2019. She gave an

invited talk titled “Anaesthetic management of a child with Tessiers type 4 for ophthalmic

surgery”.

l Dr. Jaichandran V V attended as faculty at European Society of Ophthalmic Anaesthesia congress

at Engelberg, Switzerland from 05th to 06th December 2019. He gave a talk on “Anaesthesia for

MOOKP” and participated in panel discussion titled “Teaching Ophthalmic Anaesthesia to the

New trainees”. He also conducted Sub-Tenon’s block hands-on practice session using simulator

module.

l Dr Sujatha V attended the ESOA a Switzerland from 04th to 07th December 2019.

l Dr .Meena Lakshmipathy attended the Keracon Conference at Kumarakom, Kerala from 13th to

14th December 2019. She made a presentation on “Viral Keratitis mimics”.

l Dr. Sudhir R R, Dr. Iyer Geetha Krishnan, Dr. Bhaskar Srinivasan and Dr.Mamta Agarwal

participated in the keracon conference kumarakom at kerala from 13th to 14th December 2019.

Dr.Sudhir R R , Dr. Iyer Geetha Krishnan “Keratoglobus in a 9 year old managed with limbal

sparing LK” , “AlloSLET Vs MMG in immune disorders” and “Various Kpros the Journey and

Challenges”, Dr. Mamta Agarwal presented on “Infectious Scleritis – Clinical features, diagnosis

and treatment outcome in Indian population” , “Acanthamoeba keratitis – Epidemiology, clinical

features and visual outcome” and Dr. Bhaskar Srinivasan “AMT vs AlloSLET in acute chemical

injuries” and acted as moderator for Kpro session.

l Dr. L. Dhanurekha participated in the 74th National conference of Tuberculosis and chest disease

at Chennai from 21st to 22nd December 2019.She made a poster presentation on “Genotypic

identification of Non Tuberculous Mycobacteria from culture proven isolates- A 7 years’

retrospective study from a Referral laboratory.

l Dr. Pramod Bhende Dr. Muna Bhende, Dr. Ekta Rishi Dr. Rajiv Raman, Dr. Jayaprakash V and Dr.

Vikas Khetan, attended the 28th Annual Conference of Vitreo Retinal Society, India (VRSI) at

Lucknow from 05th to 08th December 2019. Dr. Muna Bhende presented on “RAP – Clinical Profile

and Management” , Dr. Ekta Rishi on “Drusen ooze presenting with sub retinal fluid in non neo

vascular age related macular degeneration, Analysis of adverse reactions in subjects undergoing

fluorescein or indocyanine green angiography: Six years study , Salvaging an eye with

endophthalmitis and permanent keratoprosthesis”, Dr. Pramod Bhende on “Buckling in

Challenging Situations – II”, “Vitrectomy for Advanced ROP (Stage 4 & 5) Detachments”, Dr. Rajiv

Raman on “Artificial Intelligence: Dr and Beyond”, Dr. Jayaprakash V on “Acute Macular

Neuroretinopathy AMN)” Dr. Vikas Khetan on “Management of Ocular Melanomas”, and Dr.

Pradeep Susvar presented on “Macular Buckling”.

71


l Dr. Mamta Agarwal attended the KERACON 2019 at Kerala from 12th to 14th December 2019.

l Dr. Ronnie Jacob George attended the ICON 2020 at Vellore from 30th to 31st January 2020. He

gave a presentation on “Screening Strategies for Glaucoma“.

l Dr. Sujatha V K Participated in the Santen Vision Summit 2020 at Bangkok, from 09th to 11th

January 2020. She gave a presentation on “Outcomes of direct cyclopexy for repair of

cyclodialysis clefts”.

l Dr.Jaichandran V V participated in the 5th World Congress of Ophthalmic Anaesthesia (WCOA),

Jakarta, Indonesia from 7th to 8th February 2020 from 06th to 08th February 2020. He gave a talk

on “Retained Visual sensations during Eye Surgery”.

l Dr. Radhika N participated in the AIOS Conference at 13th to 16th February 2020 and has been

the IC Chief Instructor for the course titled “Customising Keratoplasty: Penetrating Keratoplasty

in the Era of Layer Transplants” , “Aphakia Management in A Grafted Eye”.

l Dr. Muna Bhende, Dr. Rajesh P S, Dr. Ronnie Jacob George, Dr. Mona Khurana, Dr. Trupti Sudhir

Patil, Dr. Sujatha V K, Dr. Smita Panda, Dr. Parveen Sen, Dr. Chetan Rao , Dr .Rajiv Raman, Dr

Dhanashree Ratra, Dr. Jyotirmay Biswas, Dr. Niveditha Narayanan and Dr. Bhaskar Srinivasan

participated in the All India Ophthalmic Society (AIOS) at Gurugram from 13th to 16th February

2020. Dr Muna Bhende presented the topic “MIRNA and LNCRNA Signature Discovery as Potential

Biomarkers in Polypoidal Choroidal Vasculopathy”, “The Glaucoma Suspect Puzzle: A Practical

Algorithm” and Dr. Niveditha Narayanan on “Clinical outcomes of DSAEK by TACO technique”.

Dr.Rajesh P S “FFA and Ultrasound”.

l Dr. Meena Lakshmipathy participated in the Sparck conference at Nagpur on 29th February 2020.

l Dr. Radhika N, Dr. Sudhir R R, Dr. Bhaskar Srinivasan, participated in the 34th Asia-Pacific

Academy of Ophthalmology Congress in Bangkok from 06th to 09th March 2019. Dr. Radhika N

presented on “Corneal Perforations Secondary to Infective Etiology - What Is The Outcome?”,

“Scleral and Rigid gas permeable contact lenses in the management of keratoconus - How Do

They Compare?", Dr. R. R. Sudhir on “How good is American Society of Cataract and Refractive

Surgery (ASCRS) Online Calculator in Predicting Cataract Surgery Outcomes in Patients Post Lasik

and Post Radial Keratotomy?”, “ Performance of an Ocularfluorometer Equipped with a Lock-In

Amplifier for Measurement of Aqueous Flare: Data from Uveitis and Post-Cataract Patients” and

Dr. Bhaskar Srinivasan presented on “Clinical Features and Cytokine Profile in Patient’s with

Recalcitrant SJS (Free Paper)".

MRF-Annual Report-2019-2020-28 Dec 2020-10-2-2021.cdr

Documents

Transcript of MRF-Annual Report-2019-2020-28 Dec 2020-10-2-2021.cdr